<SEC-DOCUMENT>0001193125-19-222479.txt : 20190815
<SEC-HEADER>0001193125-19-222479.hdr.sgml : 20190815
<ACCEPTANCE-DATETIME>20190815161811
ACCESSION NUMBER:		0001193125-19-222479
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		20
CONFORMED PERIOD OF REPORT:	20190815
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20190815
DATE AS OF CHANGE:		20190815

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CVS HEALTH Corp
		CENTRAL INDEX KEY:			0000064803
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
		IRS NUMBER:				050494040
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-01011
		FILM NUMBER:		191030461

	BUSINESS ADDRESS:	
		STREET 1:		ONE CVS DR.
		CITY:			WOONSOCKET
		STATE:			RI
		ZIP:			02895
		BUSINESS PHONE:		4017651500

	MAIL ADDRESS:	
		STREET 1:		ONE CVS DR.
		CITY:			WOONSOCKET
		STATE:			RI
		ZIP:			02895

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS CAREMARK CORP
		DATE OF NAME CHANGE:	20070509

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS/CAREMARK CORP
		DATE OF NAME CHANGE:	20070322

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS CORP
		DATE OF NAME CHANGE:	19970128
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d791446d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cvs="http://www.cvshealth.com/20190815" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>Form 8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body>
 <div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="d_2019-08-15_to_2019-08-15">CVS HEALTH Corp</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="d_2019-08-15_to_2019-08-15">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="d_2019-08-15_to_2019-08-15">0000064803</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="cvs-20190815.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="d_2019-08-15_to_2019-08-15"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2019-08-15</xbrli:startDate> <xbrli:endDate>2019-08-15</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="font-size:10pt;width:8.5in;margin:0 auto"> <div style="text-align:center"> <p style="line-height:0.5pt;border-bottom:0.50px solid #000000;width:100%;margin-top:0pt;margin-bottom:0pt">&#160;</p></div> <div style="text-align:center"> <p style="line-height:3pt;border-bottom:0.50px solid #000000;width:100%;margin-top:0pt;margin-bottom:2pt">&#160;</p></div> <p style="margin-bottom:0px;margin-top:4pt"></p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:18pt;margin-bottom:0pt;margin-top:0pt">UNITED STATES</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:18pt;margin-bottom:0pt;margin-top:0pt">SECURITIES AND EXCHANGE COMMISSION</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0pt;margin-top:0pt">Washington, D.C. 20549</p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:12pt;margin-bottom:0px">&#160;</p></div> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:18pt;margin-bottom:0px;margin-top:12pt">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="d_2019-08-15_to_2019-08-15">8-K</ix:nonNumeric></p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:12pt;margin-bottom:0px">&#160;</p></div> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0px;margin-top:12pt">CURRENT REPORT</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0pt;margin-top:0pt">Pursuant to Section&#160;13 OR 15(d)</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0pt;margin-top:0pt">of The Securities Exchange Act of 1934</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0px;margin-top:12pt">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="d_2019-08-15_to_2019-08-15" format="ixt:datemonthdayyearen"><span style="font-weight:Bold;font-style:normal">August</span><span style="font-weight:Bold;font-style:normal">&#160;15, 2019</span></ix:nonNumeric></p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:12pt;margin-bottom:0px">&#160;</p></div> <p style="font-family:Times New Roman;margin-left:0%;text-align:center;text-indent:0%;font-size:10pt;margin-bottom:0px;margin-top:12pt">
<img alt="IMAGE" src="g791446g0814071156743.jpg" /></p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:24pt;margin-bottom:0pt;margin-top:0pt"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">CVS HEALTH CORPORATION</span> </p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt">(Exact name of registrant as specified in its charter)</p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:12pt;margin-bottom:0px">&#160;</p></div>
<table cellspacing="0" cellpadding="0" border="0" style="font-size:8pt;border-collapse:separate;border-spacing:0;width:100%;margin-bottom:0px;margin-top:12pt;margin-left:auto;margin-right:auto">
<tr>
<td style="width:34%;"></td>
<td></td>
<td style="width:33%;"></td>
<td style="width:1%;"></td>
<td style="width:33%;"></td></tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="d_2019-08-15_to_2019-08-15" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="d_2019-08-15_to_2019-08-15">001-01011</ix:nonNumeric> </span></p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="d_2019-08-15_to_2019-08-15">05-0494040</ix:nonNumeric> </span></p></td></tr>
<tr style="page-break-inside:avoid;font-size:8pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(State or other jurisdiction</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">of incorporation)</p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(Commission</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">File Number)</p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(IRS Employer</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Identification No.)</p></td></tr>
<tr style="font-size:1pt;">
<td colspan="3" style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td></tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td colspan="3" style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="d_2019-08-15_to_2019-08-15">One CVS Drive</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="d_2019-08-15_to_2019-08-15">Woonsocket</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="d_2019-08-15_to_2019-08-15" format="ixt-sec:stateprovnameen">Rhode Island</ix:nonNumeric></p></td>
<td>&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="d_2019-08-15_to_2019-08-15">02895</ix:nonNumeric></p></td></tr>
<tr style="page-break-inside:avoid;font-size:8pt;">
<td colspan="3" style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(Address of principal executive offices)</p></td>
<td>&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(Zip Code)</p></td></tr></table> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0px;margin-top:12pt">Registrant&#8217;s telephone number, including area code: <span style="font-weight:Bold;font-style:normal"><ix:nonNumeric name="dei:CityAreaCode" contextRef="d_2019-08-15_to_2019-08-15">(401)</ix:nonNumeric> <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="d_2019-08-15_to_2019-08-15">765-1500</ix:nonNumeric></span></p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0px;margin-top:12pt">Former name or former address, if changed since last report: <span style="font-weight:Bold;font-style:normal">N/A</span></p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:12pt;margin-bottom:0px">&#160;</p></div> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:12pt">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:4%;vertical-align:top;white-space:nowrap;"> <span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="d_2019-08-15_to_2019-08-15" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span>&#32;</td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</td></tr></table> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:4%;vertical-align:top;white-space:nowrap;"> <span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="d_2019-08-15_to_2019-08-15" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span>&#32;</td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12) </span></td></tr></table> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:4%;vertical-align:top;white-space:nowrap;"> <span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="d_2019-08-15_to_2019-08-15" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span>&#32;</td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Pre-commencement communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b)) </span></td></tr></table> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:4%;vertical-align:top;white-space:nowrap;"> <span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="d_2019-08-15_to_2019-08-15" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span>&#32;</td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Pre-commencement communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c)) </span></td></tr></table> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:12pt">Securities registered pursuant to Section&#160;12(b) of the Act:</p>
<table cellspacing="0" cellpadding="0" border="0" style="font-size:8pt;border-collapse:separate;border-spacing:0;width:100%;margin-bottom:0px;margin-top:12pt;margin-left:auto;margin-right:auto">
<tr>
<td style="width:34%;"></td>
<td></td>
<td style="width:33%;"></td>
<td style="width:1%;"></td>
<td style="width:33%;"></td></tr>
<tr style="page-break-inside:avoid;font-size:8pt;">
<td style="border-bottom:1pt solid #000000;white-space:nowrap;vertical-align:bottom;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Title of each class</p></td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="border-bottom:1pt solid #000000;vertical-align:bottom;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Trading</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Symbol(s)</p></td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="border-bottom:1pt solid #000000;vertical-align:bottom;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Name of each exchange</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">on which registered</p></td></tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:Security12bTitle" contextRef="d_2019-08-15_to_2019-08-15">Common Stock, par value $0.01 per share</ix:nonNumeric></p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:TradingSymbol" contextRef="d_2019-08-15_to_2019-08-15">CVS</ix:nonNumeric></p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="d_2019-08-15_to_2019-08-15" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric></p></td></tr></table> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:12pt">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 (&#167;<span style="white-space:nowrap">240.12b-2</span> of this chapter).</p> <p style="font-family:Times New Roman;text-align:right;font-size:10pt;margin-bottom:0px;margin-top:12pt">Emerging growth company&#160;&#160;<span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="d_2019-08-15_to_2019-08-15" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></p> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:12pt">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;<span style="font-family:Times New Roman;font-weight:normal">&#9744;</span></p> <p style="margin-bottom:0px;margin-top:10pt"></p> <div style="text-align:center"> <p style="line-height:3pt;border-bottom:0.50px solid #000000;width:100%;margin-top:0pt;margin-bottom:0pt">&#160;</p></div> <div style="text-align:center"> <p style="line-height:3pt;border-bottom:0.50px solid #000000;width:100%;margin-top:0pt;margin-bottom:2pt">&#160;</p></div> <div></div> <p style="margin-top:0"></p></div>

<p style='page-break-before:always'> </p>
<hr style="color:#999999;height:3px;width:100%" />

 <div style="font-size:10pt;width:8.5in;margin:0 auto"> <p style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Section&#160;8 - Other Events </p> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;font-weight:bold;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:9%;vertical-align:top;white-space:nowrap;">Item&#160;8.01. </td>
<td style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Other Events</td> </tr> </table> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:6pt">On August&#160;15, 2019, CVS Health Corporation, a Delaware corporation (the &#8220;Company&#8221;), issued a press release announcing the expiration and tender results of its cash tender offers for (1)&#160;any and all of its 3.125% Senior Notes due 2020 and (2)&#160;any and all of its 4.125% Senior Notes due 2021, the 4.125% Senior Notes due 2021 issued by its wholly-owned subsidiary, Aetna Inc. (&#8220;Aetna&#8221;) and the 5.450% Senior Notes due 2021 issued by Coventry Health Care, Inc., a wholly-owned subsidiary of Aetna, in connection with the Company&#8217;s previously announced cash tender offers commenced on August&#160;8, 2019. </p> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:12pt">On August&#160;15, 2019, the Company issued and sold $1,000,000,000 aggregate principal amount of its 2.625% senior notes due August&#160;15, 2024 (the &#8220;2024 Notes&#8221;), $750,000,000 aggregate principal amount of its 3.000% senior notes due August&#160;15, 2026 (the &#8220;2026 Notes&#8221;) and $1,750,000,000 aggregate principal amount of its 3.250% senior notes due August&#160;15, 2029 (the &#8220;2029 Notes&#8221; and, together with the 2024 Notes and the 2026 Notes, the &#8220;Notes&#8221;). The Notes were offered pursuant to the Company&#8217;s Registration Statement on Form <span style="white-space:nowrap">S-3ASR,</span> File&#160;No.<span style="white-space:nowrap">&#160;333-217596,</span>&#160;dated May&#160;2, 2017 (the &#8220;Registration Statement&#8221;). </p> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:12pt">The Notes are governed by and issued pursuant to a Senior Indenture dated August&#160;15, 2006 between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee (the &#8220;Senior Indenture&#8221;). The Company may issue additional senior debt securities from time to time pursuant to the Senior Indenture. The form of Senior Indenture was filed as <a href="http://www.sec.gov/Archives/edgar/data/64803/000095010306001962/ex0401.htm">Exhibit 4.1</a> to the Company&#8217;s Current Report on Form<span style="white-space:nowrap">&#160;8-K</span>&#160;filed August&#160;15, 2006 and shall be incorporated by reference into this Current Report on Form<span style="white-space:nowrap">&#160;8-K.</span>&#160;Forms of the Notes are filed as Exhibits 4.1, 4.2 and 4.3 to this Current Report on Form<span style="white-space:nowrap">&#160;8-K</span>&#160;and are incorporated by reference into the Registration Statement. </p> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:12pt">A copy of the press release is attached hereto as Exhibit 99.1, which is incorporated by reference herein. </p> <p style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:18pt">Section&#160;9 - Financial Statements and Exhibits </p> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;font-weight:bold;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:9%;vertical-align:top;white-space:nowrap;">Item&#160;9.01 </td>
<td style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Financial Statements and Exhibits.</td> </tr> </table> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;font-weight:bold;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:4%;vertical-align:top;white-space:nowrap;">(d) </td>
<td style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;"> <span style="text-decoration:underline">Exhibits</span>.</td> </tr> </table> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:12pt">The exhibit to this Current Report on Form <span style="white-space:nowrap">8-K</span> is as follows: </p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0px;margin-top:24pt">INDEX TO EXHIBITS </p>
<table cellspacing="0" cellpadding="0" border="0" style="font-size:10pt;border-collapse:separate;border-spacing:0;width:100%;margin-bottom:0px;margin-top:12pt;margin-left:auto;margin-right:auto">
<tr>
<td></td>
<td></td>
<td></td>
<td style="width:3%;"></td>
<td style="width:94%;"></td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="white-space:nowrap;vertical-align:top;padding:0;font-family:Times New Roman;font-weight:bold;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="white-space:nowrap;vertical-align:top;padding:0;text-align:left"> <p style="font-family:Times New Roman;font-weight:bold;font-size:10pt;margin-bottom:0pt;margin-top:0pt">4.1 </p> </td>
<td style="white-space:nowrap;vertical-align:top;padding-right:2pt;font-weight:bold;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;margin-left:0.00em;text-align:left;text-indent:0.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <a href="d791446dex41.htm">Form of the 2024 Note </a> </p> </td> </tr>
<tr style="font-size:1pt;">
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="white-space:nowrap;vertical-align:top;padding:0;font-family:Times New Roman;font-weight:bold;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="white-space:nowrap;vertical-align:top;padding:0;text-align:left"> <p style="font-family:Times New Roman;font-weight:bold;font-size:10pt;margin-bottom:0pt;margin-top:0pt">4.2 </p> </td>
<td style="white-space:nowrap;vertical-align:top;padding-right:2pt;font-weight:bold;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;margin-left:0.00em;text-align:left;text-indent:0.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <a href="d791446dex42.htm">Form of the 2026 Note </a> </p> </td> </tr>
<tr style="font-size:1pt;">
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="white-space:nowrap;vertical-align:top;padding:0;font-family:Times New Roman;font-weight:bold;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="white-space:nowrap;vertical-align:top;padding:0;text-align:left"> <p style="font-family:Times New Roman;font-weight:bold;font-size:10pt;margin-bottom:0pt;margin-top:0pt">4.3 </p> </td>
<td style="white-space:nowrap;vertical-align:top;padding-right:2pt;font-weight:bold;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;margin-left:0.00em;text-align:left;text-indent:0.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <a href="d791446dex43.htm">Form of the 2029 Note </a> </p> </td> </tr>
<tr style="font-size:1pt;">
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="white-space:nowrap;vertical-align:top;padding:0;font-family:Times New Roman;font-weight:bold;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="white-space:nowrap;vertical-align:top;padding:0;text-align:left"> <p style="font-family:Times New Roman;font-weight:bold;font-size:10pt;margin-bottom:0pt;margin-top:0pt">5.1 </p> </td>
<td style="white-space:nowrap;vertical-align:top;padding-right:2pt;font-weight:bold;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;margin-left:0.00em;text-align:left;text-indent:0.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <a href="d791446dex51.htm">Opinion of Shearman&#160;&#038; Sterling LLP </a> </p> </td> </tr>
<tr style="font-size:1pt;">
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="white-space:nowrap;vertical-align:top;padding:0;font-family:Times New Roman;font-weight:bold;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="white-space:nowrap;vertical-align:top;padding:0;text-align:left"> <p style="font-family:Times New Roman;font-weight:bold;font-size:10pt;margin-bottom:0pt;margin-top:0pt">23.1 </p> </td>
<td style="white-space:nowrap;vertical-align:top;padding-right:2pt;font-weight:bold;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;margin-left:0.00em;text-align:left;text-indent:0.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <a href="d791446dex51.htm">Consent of Shearman&#160;&#038; Sterling LLP (included in Exhibit 5.1) </a> </p> </td> </tr>
<tr style="font-size:1pt;">
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="white-space:nowrap;vertical-align:top;padding:0;font-family:Times New Roman;font-weight:bold;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="white-space:nowrap;vertical-align:top;padding:0;text-align:left"> <p style="font-family:Times New Roman;font-weight:bold;font-size:10pt;margin-bottom:0pt;margin-top:0pt">99.1 </p> </td>
<td style="white-space:nowrap;vertical-align:top;padding-right:2pt;font-weight:bold;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;margin-left:0.00em;text-align:left;text-indent:0.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <a href="d791446dex991.htm">Press Release of CVS Health Corporation dated August&#160;15, 2019 </a> </p> </td> </tr>
<tr style="font-size:1pt;">
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="white-space:nowrap;vertical-align:top;padding:0;font-family:Times New Roman;font-weight:bold;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="white-space:nowrap;vertical-align:top;padding:0;text-align:left"> <p style="font-family:Times New Roman;font-weight:bold;font-size:10pt;margin-bottom:0pt;margin-top:0pt">104 </p> </td>
<td style="white-space:nowrap;vertical-align:top;padding-right:2pt;font-weight:bold;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;margin-left:0.00em;text-align:left;text-indent:0.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Cover Page Interactive File (the cover page tags are embedded within the Inline XBRL document). </p> </td> </tr> </table> <div></div> <p style="margin-top:0"></p>
 </div>


<p style='page-break-before:always'> </p>
<hr style="color:#999999;height:3px;width:100%" />

 <div style="font-size:10pt;width:8.5in;margin:0 auto"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt">SIGNATURES </p> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:12pt">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p>
<table cellspacing="0" cellpadding="0" border="0" style="font-size:10pt;border-collapse:separate;border-spacing:0;width:100%;margin-bottom:0px;margin-top:12pt;margin-left:0px;margin-right:auto">
<tr>
<td style="width:46%;"></td>
<td style="width:1%;"></td>
<td style="width:4%;"></td>
<td></td>
<td style="width:2%;"></td>
<td style="width:1%;"></td>
<td style="width:45%;"></td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">CVS HEALTH CORPORATION </p> </td> </tr>
<tr style="font-size:1pt;">
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Date: August&#160;15, 2019 </p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">By: </p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;font-style:italic;text-align:left;margin-bottom:1pt;font-size:10pt;margin-top:0pt;border-bottom:1px solid #000000">/s/ Eva C. Boratto </p> </td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Eva C. Boratto </p> </td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Executive Vice President and Chief Financial Officer </p> </td> </tr> </table> <div></div> <p style="margin-top:0"></p>
 </div>
 </body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>d791446dex41.htm
<DESCRIPTION>EX-4.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY (&#147;DTC&#148;), TO THE COMPANY OR ITS
AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE&nbsp;&amp; CO. OR SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO
CEDE&nbsp;&amp; CO., OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF,
CEDE&nbsp;&amp; CO., HAS AN INTEREST HEREIN. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">UNLESS AND UNTIL THIS GLOBAL NOTE IS EXCHANGED IN WHOLE OR IN PART FOR A GLOBAL NOTE IN
DEFINITIVE REGISTERED FORM, THIS GLOBAL NOTE MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY DTC TO A NOMINEE OF DTC OR BY A NOMINEE OF DTC TO DTC OR ANOTHER NOMINEE OF DTC OR BY DTC OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH
SUCCESSOR DEPOSITARY. </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CVS HEALTH CORPORATION </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">No.&nbsp;[&#9679;]</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">$[&#9679;]</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CUSIP No.&nbsp;126650 DE7 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ISIN
No.&nbsp;US126650DE72 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2.625% Senior Note due 2024 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">CVS HEALTH CORPORATION, a Delaware corporation (such corporation, and its successors and assigns under the Indenture hereinafter referred to,
being herein called the &#147;<B>Company</B>&#148;), for value received promises to pay to CEDE&nbsp;&amp; CO., or registered assigns, the principal sum of $[&#9679;] on August&nbsp;15, 2024. If such maturity date is not a Business Day, then payment
of principal will be made on the next succeeding Business Day and no interest will accrue on the amount so payable for the period from such maturity date to the date payment is made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest Payment Dates: February 15 and August 15. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Record Dates: Each February&nbsp;1 and August&nbsp;1, immediately preceding each Interest Payment Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additional provisions of this Note are set forth on the reverse side of this Note. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Remainder of page intentionally left blank</I>] </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Company has caused this Note to be duly executed. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>CVS HEALTH CORPORATION</B></TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Note No. [</I><I></I>&#9679;<I></I><I></I><I>] of 2024 Notes</I>] </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: August&nbsp;15, 2019 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TRUSTEE&#146;S CERTIFICATE OF AUTHENTICATION </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THE BANK OF NEW
YORK MELLON TRUST COMPANY, N.A., </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">as Trustee, certifies that this is one of the Debt Securities referred to </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">in the Indenture. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Authorized Signatory</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Note No. [</I><I></I>&#9679;<I></I><I></I><I>] of 2024 Notes</I>] </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2.625% Senior Note due 2024 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note is one of a duly authorized series of Notes of CVS Health Corporation, a Delaware corporation (such corporation, and its successors
and assigns under the Indenture hereinafter referred to, being herein called the &#147;<B>Company</B>&#148;), designated as its 2.625% Senior Notes due 2024 (hereinafter referred to as the &#147;<B>Notes</B>&#148;). </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Interest </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company promises to pay interest on the principal amount of this Note at the rate per annum shown above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will pay interest on the Notes semi-annually on February&nbsp;15 and August&nbsp;15 of each year, commencing February&nbsp;15,
2020. Interest on the Notes will accrue from the most recent date to which interest has been paid or provided for, or, if no interest has been paid or provided for, from August&nbsp;15, 2024. Interest will be computed on the basis of a <FONT
STYLE="white-space:nowrap">360-day</FONT> year of twelve <FONT STYLE="white-space:nowrap">30-day&nbsp;months.</FONT> The Company shall pay interest on overdue principal at the rate borne by the Notes. If any interest payment date is not a Business
Day, then payment of interest will be made on the next succeeding Business Day and no interest will accrue on the amount so payable for the period from such interest payment date to the date payment is made. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Method of Payment </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will pay interest on the Notes (except defaulted interest) to the Persons who are registered Holders thereof at the close of
business on the February&nbsp;1 and August&nbsp;1 (whether or not a Business Day) immediately preceding the interest payment date even if the Notes are canceled after the record date and on or before the interest payment date. Holders must surrender
Notes to a Paying Agent to collect principal payments. The Company will pay principal, premium, if any, and interest in money of the United States that at the time of payment is legal tender for payment of public and private debts by wire transfer
of immediately available funds to the accounts specified by the Holders, or, if no such account is specified, the Company may pay principal and interest by check payable in such money. It may mail an interest check to a Holder&#146;s registered
address. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Paying Agent and Registrar </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Initially, The Bank of New York Mellon Trust Company, N.A., a national banking association (the &#147;<B>Trustee</B>&#148;), will act as Paying
Agent and Registrar. The Company may appoint and change any Paying Agent, Registrar or <FONT STYLE="white-space:nowrap">co-registrar</FONT> without notice. The Company or any of its domestically incorporated Wholly Owned Subsidiaries may act as
Paying Agent, Registrar or <FONT STYLE="white-space:nowrap">co-registrar.</FONT> </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Indenture </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company issued the Notes under an Indenture dated as of August&nbsp;15, 2006 (the &#147;<B>Indenture</B>&#148;), between the Company and
the Trustee. The terms of the Notes include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939 (15 U.S.C. ss.ss. 77aaa-77bbbb) as in effect on the date of the Indenture (the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
&#147;<B>TIA</B>&#148;). Terms defined in the Indenture and not defined herein have the meanings ascribed thereto in the Indenture. The Notes are subject to all such terms, and Holders of Notes
are referred to the Indenture and the TIA for a statement of those terms. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes are general unsecured senior obligations of the
Company initially limited to $1,000,000,000 aggregate principal amount (subject to Section&nbsp;2.08 of the Indenture). The Company may at any time issue additional Notes under the Indenture in unlimited amounts having the same terms as and treated
as a single class with the Notes for all purposes under the Indenture and will vote together as one class with respect to the Notes. The Indenture imposes certain limitations on the incurrence of certain additional indebtedness by the Company and
certain of its subsidiaries and the entry into certain sale and leaseback arrangements by the Company and certain of its subsidiaries. The Indenture also restricts the ability of the Company to consolidate or merge with or into, or to transfer all
or substantially all its assets to, another person. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Optional Redemption </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to July&nbsp;15, 2024, the Company, at its option, may at any time redeem all or any portion of the Notes upon not less than 15 nor more
than 60 days&#146; notice, at a redemption price, plus accrued and unpaid interest, if any, to, but excluding, the redemption date, equal to the greater of (i)&nbsp;100% of the aggregate principal amount of the Notes being redeemed or (ii)&nbsp;the
sum of the present values of the remaining scheduled payments of principal and interest on the Notes being redeemed (not including any portion of such payments of interest accrued to the redemption date) discounted to the redemption date on a
semiannual basis (assuming a <FONT STYLE="white-space:nowrap">360-day</FONT> year consisting of twelve <FONT STYLE="white-space:nowrap">30-day&nbsp;months)</FONT> at the applicable Treasury Yield plus 20 basis points. If any redemption date is not a
Business Day, then payment of the redemption price and accrued and unpaid interest will be made on the next succeeding Business Day, and no interest will accrue on the amounts so payable for the period from such redemption date to the date payment
is made. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Comparable Treasury Issue</B>&#148; means the United States Treasury security selected by an Independent Investment
Banker as having a maturity comparable to the remaining term of the Notes that would be utilized, at the time of selection and in accordance with customary financial practice, in pricing new issues of corporate debt securities of comparable maturity
to such remaining term. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Comparable Treasury Price</B>&#148; means, with respect to any redemption date, (i)&nbsp;the average of
the applicable Reference Treasury Dealer Quotations for such redemption date, after excluding the highest and lowest such applicable Reference Treasury Dealer Quotations, or (ii)&nbsp;if the Independent Investment Banker obtains fewer than four such
Reference Treasury Dealer Quotations, the average of all such Reference Treasury Dealer Quotations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Independent Investment
Banker</B>&#148; means Barclays Capital Inc. or, if such firm is unwilling or unable to select the applicable Comparable Treasury Issue, an independent investment banking institution of national standing appointed by the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Reference Treasury Dealer</B>&#148; means (i)&nbsp;Barclays Capital Inc., Goldman
Sachs&nbsp;&amp; Co. LLC and J.P. Morgan Securities LLC and their respective successors; <I>provided</I>, <I>however</I>, that if any of the foregoing shall cease to be a primary United States government securities dealer in New York City (a
&#147;<B>Primary Treasury Dealer</B>&#148;), the Company shall substitute therefor another Primary Treasury Dealer and (ii)&nbsp;any other Primary Treasury Dealer selected by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Reference Treasury Dealer Quotations</B>&#148; means, with respect to each Reference Treasury Dealer and any redemption date, the
average, as determined by the Independent Investment Banker, of the bid and asked prices for the Comparable Treasury Issue for the Notes (expressed in each case as a percentage of its aggregate principal amount) quoted in writing to the Independent
Investment Banker by such Reference Treasury Dealer at 5:00&nbsp;p.m., New York City time, on the third business day preceding such redemption date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Treasury Yield</B>&#148; means, with respect to any redemption date, the rate per annum equal to the semiannual equivalent yield to
maturity of the Comparable Treasury Issue, assuming a price for the Comparable Treasury Issue (expressed as a percentage of its aggregate principal amount) equal to the applicable Comparable Treasury Price for such redemption date. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Notice of Optional Redemption </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notice of redemption shall be transmitted by the Company (or, at the Company&#146;s request, by the Trustee on the Company&#146;s behalf) to
each Holder of Notes to be redeemed. Notes in denominations larger than $2,000 may be redeemed in part but only in whole multiples of $1,000. If money sufficient to pay the redemption price of and accrued interest on all Notes (or portions thereof)
to be redeemed on the redemption date is deposited with the Paying Agent on or before the redemption date and certain other conditions are satisfied, on and after such date interest ceases to accrue on such Notes (or such portions thereof) called
for redemption. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Repurchase of the Notes Upon a Change of Control Triggering Event </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a Change of Control Triggering Event (as defined below) occurs, Holders of the Notes will have the right to require the Company to
repurchase all or any part (in integral multiples of $1,000 original principal amount) of their Notes pursuant to the offer described below (&#147;<B>Change of Control Offer</B>&#148;) on the terms set forth in this Note. In the Change of Control
Offer, the Company will be required to offer payment in cash equal to 101% of the aggregate principal amount of Notes repurchased plus accrued and unpaid interest, if any, on the Notes repurchased, to, but excluding, the date of purchase
(&#147;<B>Change of Control Payment</B>&#148;). Within 30 days following any Change of Control Triggering Event, the Company will be required to mail a notice to Holders of Notes describing the transaction or transactions that constitute the Change
of Control Triggering Event and offering to repurchase the Notes on the date specified in the notice, which date will be no earlier than 30 days and no later than 60 days from the date such notice is mailed (&#147;<B>Change of Control Payment
Date</B>&#148;), pursuant to the procedures required by the Notes and described in such notice. The Company must comply with the requirements of Rule <FONT STYLE="white-space:nowrap">14e-1</FONT> under the Exchange Act and any other securities laws
and regulations thereunder to the extent those laws and regulations are applicable in connection with the repurchase of the Notes as a result of a Change of Control Triggering Event. To the extent that the provisions of any securities laws or
regulations conflict with the Change of Control provisions of the Notes, the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Company will be required to comply with the applicable securities laws and regulations and will not be deemed to have breached its obligations under the Change of Control provisions of the Notes
by virtue of such conflicts and compliance with law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On the Change of Control Payment Date, the Company will be required, to the extent
lawful, to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">accept for payment all Notes properly tendered pursuant to the Change of Control Offer; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">deposit with the Paying Agent an amount equal to the Change of Control Payment in respect of all Notes or
portions of Notes properly tendered; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">deliver or cause to be delivered to the Trustee the Notes properly accepted together with an Officers&#146;
Certificate stating the aggregate principal amount of Notes or portions of Notes being purchased. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will not
be required to make a Change of Control Offer upon the occurrence of a Change of Control Triggering Event if a third party makes such an offer in the manner, at the times and otherwise in compliance with the requirements for an offer made by the
Company and the third party repurchases all Notes properly tendered and not withdrawn under its offer. In addition, the Company will not repurchase any Notes if there has occurred and is continuing on the Change of Control Payment Date an event of
default under the Indenture, other than a default in the payment of the Change of Control Payment upon a Change of Control Triggering Event. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of the foregoing, the following definitions are applicable: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Below Investment Grade Rating Event</B>&#148; means that the Notes are rated below an Investment Grade Rating by each of the Rating
Agencies (as defined below) on any date from the date of the public notice of an arrangement that could result in a Change of Control until the end of the <FONT STYLE="white-space:nowrap">60-day</FONT> period following public notice of the
occurrence of the Change of Control (which <FONT STYLE="white-space:nowrap">60-day</FONT> period shall be extended so long as the rating of the Notes is under publicly announced consideration for possible downgrade by any of the Rating Agencies);
<I>provided</I>, <I>however</I>, that a Below Investment Grade Rating Event otherwise arising by virtue of a particular reduction in rating will not be deemed to have occurred in respect of a particular Change of Control (and thus will not be deemed
a Below Investment Grade Rating Event for purposes of the definition of Change of Control Triggering Event) if the Rating Agencies making the reduction in rating to which this definition would otherwise apply do not announce or publicly confirm or
inform the Trustee in writing at the Company&#146;s or the Trustee&#146;s request that the reduction was the result, in whole or in part, of any event or circumstance comprised of or arising as a result of, or in respect of, the applicable Change of
Control (whether or not the applicable Change of Control has occurred at the time of the Below Investment Grade Rating Event). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Change of Control</B>&#148; means the occurrence of any of the following:
(1)&nbsp;any event requiring the filing of any report under or in response to Schedule 13D or <FONT STYLE="white-space:nowrap">14D-1</FONT> pursuant to the Securities Exchange Act of 1934, as amended (the &#147;<B>Exchange Act</B>&#148;) disclosing
beneficial ownership of either 50% or more of the Company&#146;s common stock then outstanding or 50% or more of its voting power or its voting stock then outstanding; (2)&nbsp;the direct or indirect sale, transfer, conveyance or other disposition
(other than by way of merger or consolidation), in one or a series of related transactions, of all or substantially all of the properties or the Company&#146;s assets and the assets of its respective subsidiaries taken as a whole to one or more
persons (as defined in the Indenture) other than the Company or one of its subsidiaries; or (3)&nbsp;the first day on which a majority of the members of the Company&#146;s Board of Directors are not Continuing Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, a transaction will not be deemed to involve a Change of Control if (1)&nbsp;the Company becomes a direct or
indirect wholly-owned subsidiary of a holding company and (2)(A) the direct or indirect holders of the voting stock of such holding company immediately following that transaction are substantially the same as the holders of the Company&#146;s voting
stock immediately prior to that transaction or (B)&nbsp;immediately following that transaction no person (other than a holding company satisfying the requirements of this sentence) is the beneficial owner, directly or indirectly, of more than 50% of
the voting stock of such holding company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Change of Control Triggering Event</B>&#148; means the occurrence of both a Change of
Control and a Below Investment Grade Rating Event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Continuing Director</B>&#148; means, as of any date of determination, any
member of the Company&#146;s Board of Directors who (1)&nbsp;was a member of such Board of Directors on the date of the issuance of the Notes; or (2)&nbsp;was nominated for election or elected to such Board of Directors with the approval of a
majority of the Continuing Directors who were members of such Board of Directors at the time of such nomination or election (either by a specific vote or by approval of the Company&#146;s proxy statement in which such member was named as a nominee
for election as a director, without objection to such nomination). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Investment Grade Rating</B>&#148; means a rating equal to or
higher than Baa3 (or the equivalent) by Moody&#146;s and <FONT STYLE="white-space:nowrap">BBB-</FONT> (or the equivalent) by S&amp;P. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Moody&#146;s</B>&#148; means Moody&#146;s Investors Service, Inc., or its successor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Rating Agencies</B>&#148; means (1)&nbsp;each of Moody&#146;s and S&amp;P; and (2)&nbsp;if any of Moody&#146;s or S&amp;P ceases to
rate the Notes or fails to make a rating of the Notes publicly available for reasons outside of the Company&#146;s control, a &#147;nationally recognized statistical rating organization&#148; within the meaning of Rule 3(a)(62) under the Exchange
Act selected by the Company (as certified by a resolution of the Company&#146;s Board of Directors) as a replacement agency for Moody&#146;s or S&amp;P, or both of them, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>S&amp;P</B>&#148; means S&amp;P Global Ratings, a division of S&amp;P Global Inc., or its successor. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Denominations; Transfer; Exchange </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes are in registered form without coupons in denominations of $2,000 and integral multiples of $1,000 in excess thereof. Holders of
Notes may transfer or exchange Notes </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
in accordance with the Indenture. The Registrar may require a Holder of Notes, among other things, to furnish appropriate endorsements or transfer documents and to pay any taxes and fees required
by law or permitted by the Indenture. The Registrar need not register the transfer of or exchange any Notes selected for redemption (except, in the case of a Note to be redeemed in part, the portion of the Note not to be redeemed) or any Notes for a
period of 15&nbsp;days before a selection of Notes to be redeemed or 15&nbsp;days before an interest payment date. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Persons Deemed Owners </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The registered Holder of this Note may be treated as the sole owner of such Note for all purposes. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(j)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Unclaimed Money </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to applicable abandoned property law, if money for the payment of principal or interest remains unclaimed for two years, the Trustee or
Paying Agent shall pay the money back to the Company at its request unless an abandoned property law designates another Person. After any such payment, Holders entitled to the money must look only to the Company and not to the Trustee or Paying
Agent for payment. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(k)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Discharge and Defeasance </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain conditions, the Company at any time may terminate some or all of its obligations under the Notes and the Indenture if the
Company deposits with the Trustee money or U.S. Government Obligations for the payment of principal and interest on the Notes to redemption or maturity, as the case may be. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(l)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Amendment; Waiver </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain exceptions set forth in the Indenture, (i)&nbsp;the Indenture or the Notes may be amended with the written consent of the
Holders of at least a majority in principal amount outstanding of the Notes; and (ii)&nbsp;any default or compliance with any provision may be waived with the written consent of the Holders of a majority in principal amount of the Notes then
outstanding. Subject to certain exceptions set forth in the Indenture, without the consent of any Holder of a Note, the Company and the Trustee may amend the Indenture or the Notes to cure any ambiguity, omission, defect or inconsistency that does
not materially and adversely affect the rights of any Holder of a Note, or to comply with Article&nbsp;5 of the Indenture or to comply with requirements of the SEC in connection with the qualification of the Indenture under the TIA. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(m)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Defaults and Remedies </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If an Event of Default occurs and is continuing, the Trustee or the Holders of at least 25% in aggregate principal amount of the Notes may
declare all the Notes to be due and payable immediately. Certain events of bankruptcy or insolvency are Events of Default which will result in the Notes being due and payable immediately upon the occurrence of such Events of Default. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Holders of Notes may not enforce the Indenture or the Notes except as provided in the Indenture. The Trustee may refuse to enforce the
Indenture or the Notes unless it receives </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
indemnity or security satisfactory to it. Subject to certain limitations, Holders of a majority in principal amount of the Notes may direct the Trustee in its exercise of any trust or power. The
Trustee may withhold from Holders of Notes notice of any continuing Default (except a Default in payment of principal or interest) if it determines that withholding such notice is in the interest of the Holders of Notes. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(n)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Trustee Dealings with the Company </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain limitations imposed by the TIA, the Trustee under the Indenture, in its individual or any other capacity, may become the
owner or pledgee of Notes and may otherwise deal with and collect obligations owed to it by the Company or its Affiliates and may otherwise deal with the Company or its Affiliates with the same rights it would have if it were not Trustee. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(o)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No Recourse Against Others </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A director, officer, employee or stockholder, as such, of the Company or the Trustee shall not have any liability for any obligations of the
Company under the Notes or the Indenture or for any claim based on, in respect of or by reason of such obligations. By accepting a Note, each Holder of a Note waives and releases all such liability. The waiver and release are part of the
consideration for the issue of the Notes. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(p)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Authentication </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note shall not be valid until an authorized signatory of the Trustee (or an authenticating agent) manually signs the certificate of
authentication on the face of this Note. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(q)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Abbreviations </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Customary abbreviations may be used in the name of a Holder of a Note or an assignee, such as TEN COM (=tenants in common), TEN ENT (=tenants
by the entireties), JT TEN (=joint tenants with rights of survivorship and not as tenants in common), CUST (=custodian), and U/G/M/A (=Uniform Gift to Minors Act). </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(r)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Governing Law </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note shall be governed by, and construed in accordance with, the laws of the State of New York. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(s)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">CUSIP Numbers </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the recommendation promulgated by the Committee on Uniform Security Identification Procedures, the Company has caused CUSIP numbers
to be printed on the Notes and has directed the Trustee to use such CUSIP numbers in notices of redemption as a convenience to Holders of Notes. No representation is made as to the accuracy of such numbers either as printed on the Notes or as
contained in any notice of redemption and reliance may be placed only on the other identification numbers placed thereon. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will furnish to any Holder of a Note upon written request and without charge to
such Holder of a Note a copy of the Indenture. Requests may be made to: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CVS Health Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">One CVS Drive &#151; MC 1008 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Woonsocket, Rhode Island 02895 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention: Valerie Haertel </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Terms
defined in the Indenture and not otherwise defined herein are used herein as therein defined. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ASSIGNMENT FORM </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">To assign this Note, complete the form below: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">I or we assign and transfer this Note to: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Print or type assignee&#146;s name, address and zip code] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Insert assignee&#146;s soc. sec. or tax I.D. No.] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">and irrevocably appoint
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> as agent to </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">transfer this Note on the books of CVS Health Corporation. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The agent may substitute another to act for him. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="42%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="39%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Date:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Your&nbsp;Signature:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sign exactly as your name appears on the face of this Note. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>d791446dex42.htm
<DESCRIPTION>EX-4.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY (&#147;DTC&#148;), TO THE COMPANY OR ITS
AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE&nbsp;&amp; CO. OR SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO
CEDE&nbsp;&amp; CO., OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF,
CEDE&nbsp;&amp; CO., HAS AN INTEREST HEREIN. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">UNLESS AND UNTIL THIS GLOBAL NOTE IS EXCHANGED IN WHOLE OR IN PART FOR A GLOBAL NOTE IN
DEFINITIVE REGISTERED FORM, THIS GLOBAL NOTE MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY DTC TO A NOMINEE OF DTC OR BY A NOMINEE OF DTC TO DTC OR ANOTHER NOMINEE OF DTC OR BY DTC OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH
SUCCESSOR DEPOSITARY. </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CVS HEALTH CORPORATION </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">No.&nbsp;[&#9679;]</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">$[&#9679;]</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CUSIP No.&nbsp;126650 DF4 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ISIN
No.&nbsp;US126650DF48 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3.000% Senior Note due 2026 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">CVS HEALTH CORPORATION, a Delaware corporation (such corporation, and its successors and assigns under the Indenture hereinafter referred to,
being herein called the &#147;<B>Company</B>&#148;), for value received promises to pay to CEDE&nbsp;&amp; CO., or registered assigns, the principal sum of $[&#9679;] on August&nbsp;15, 2026. If such maturity date is not a Business Day, then payment
of principal will be made on the next succeeding Business Day and no interest will accrue on the amount so payable for the period from such maturity date to the date payment is made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest Payment Dates: February&nbsp;15 and August 15. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Record Dates: Each February&nbsp;1 and August&nbsp;1, immediately preceding each Interest Payment Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additional provisions of this Note are set forth on the reverse side of this Note. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Remainder of page intentionally left blank</I>] </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Company has caused this Note to be duly executed. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>CVS HEALTH CORPORATION</B></TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Note No. [</I><I></I>&#9679;<I></I><I></I><I>] of 2026 Notes</I>] </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: August&nbsp;15, 2019 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TRUSTEE&#146;S CERTIFICATE OF AUTHENTICATION </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THE BANK OF NEW
YORK MELLON TRUST COMPANY, N.A., </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">as Trustee, certifies that this is one of the Debt Securities referred to </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">in the Indenture. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Authorized Signatory</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Note No. [</I><I></I>&#9679;<I></I><I></I><I>] of 2026 Notes</I>] </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3.000% Senior Note due 2026 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note is one of a duly authorized series of Notes of CVS Health Corporation, a Delaware corporation (such corporation, and its successors
and assigns under the Indenture hereinafter referred to, being herein called the &#147;<B>Company</B>&#148;), designated as its 3.000% Senior Notes due 2026 (hereinafter referred to as the &#147;<B>Notes</B>&#148;). </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Interest </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company promises to pay interest on the principal amount of this Note at the rate per annum shown above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will pay interest on the Notes semi-annually on February&nbsp;15 and August&nbsp;15 of each year, commencing February&nbsp;15,
2020. Interest on the Notes will accrue from the most recent date to which interest has been paid or provided for, or, if no interest has been paid or provided for, from August&nbsp;15, 2019. Interest will be computed on the basis of a <FONT
STYLE="white-space:nowrap">360-day</FONT> year of twelve <FONT STYLE="white-space:nowrap">30-day&nbsp;months.</FONT> The Company shall pay interest on overdue principal at the rate borne by the Notes. If any interest payment date is not a Business
Day, then payment of interest will be made on the next succeeding Business Day and no interest will accrue on the amount so payable for the period from such interest payment date to the date payment is made. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Method of Payment </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will pay interest on the Notes (except defaulted interest) to the Persons who are registered Holders thereof at the close of
business on the February&nbsp;1 and August&nbsp;1 (whether or not a Business Day) immediately preceding the interest payment date even if the Notes are canceled after the record date and on or before the interest payment date. Holders must surrender
Notes to a Paying Agent to collect principal payments. The Company will pay principal, premium, if any, and interest in money of the United States that at the time of payment is legal tender for payment of public and private debts by wire transfer
of immediately available funds to the accounts specified by the Holders, or, if no such account is specified, the Company may pay principal and interest by check payable in such money. It may mail an interest check to a Holder&#146;s registered
address. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Paying Agent and Registrar </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Initially, The Bank of New York Mellon Trust Company, N.A., a national banking association (the &#147;<B>Trustee</B>&#148;), will act as Paying
Agent and Registrar. The Company may appoint and change any Paying Agent, Registrar or <FONT STYLE="white-space:nowrap">co-registrar</FONT> without notice. The Company or any of its domestically incorporated Wholly Owned Subsidiaries may act as
Paying Agent, Registrar or <FONT STYLE="white-space:nowrap">co-registrar.</FONT> </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Indenture </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company issued the Notes under an Indenture dated as of August&nbsp;15, 2006 (the &#147;<B>Indenture</B>&#148;), between the Company and
the Trustee. The terms of the Notes include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939 (15 U.S.C. ss.ss. 77aaa-77bbbb) as in effect on the date of the Indenture (the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
&#147;<B>TIA</B>&#148;). Terms defined in the Indenture and not defined herein have the meanings ascribed thereto in the Indenture. The Notes are subject to all such terms, and Holders of Notes
are referred to the Indenture and the TIA for a statement of those terms. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes are general unsecured senior obligations of the
Company initially limited to $750,000,000 aggregate principal amount (subject to Section&nbsp;2.08 of the Indenture). The Company may at any time issue additional Notes under the Indenture in unlimited amounts having the same terms as and treated as
a single class with the Notes for all purposes under the Indenture and will vote together as one class with respect to the Notes. The Indenture imposes certain limitations on the incurrence of certain additional indebtedness by the Company and
certain of its subsidiaries and the entry into certain sale and leaseback arrangements by the Company and certain of its subsidiaries. The Indenture also restricts the ability of the Company to consolidate or merge with or into, or to transfer all
or substantially all its assets to, another person. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Optional Redemption </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to June&nbsp;15, 2026, the Company, at its option, may at any time redeem all or any portion of the Notes upon not less than 15 nor more
than 60 days&#146; notice, at a redemption price, plus accrued and unpaid interest, if any, to, but excluding, the redemption date, equal to the greater of (i)&nbsp;100% of the aggregate principal amount of the Notes being redeemed or (ii)&nbsp;the
sum of the present values of the remaining scheduled payments of principal and interest on the Notes being redeemed (not including any portion of such payments of interest accrued to the redemption date) discounted to the redemption date on a
semiannual basis (assuming a <FONT STYLE="white-space:nowrap">360-day</FONT> year consisting of twelve <FONT STYLE="white-space:nowrap">30-day&nbsp;months)</FONT> at the applicable Treasury Yield plus 25 basis points. If any redemption date is not a
Business Day, then payment of the redemption price and accrued and unpaid interest will be made on the next succeeding Business Day, and no interest will accrue on the amounts so payable for the period from such redemption date to the date payment
is made. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Comparable Treasury Issue</B>&#148; means the United States Treasury security selected by an Independent Investment
Banker as having a maturity comparable to the remaining term of the Notes that would be utilized, at the time of selection and in accordance with customary financial practice, in pricing new issues of corporate debt securities of comparable maturity
to such remaining term. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Comparable Treasury Price</B>&#148; means, with respect to any redemption date, (i)&nbsp;the average of
the applicable Reference Treasury Dealer Quotations for such redemption date, after excluding the highest and lowest such applicable Reference Treasury Dealer Quotations, or (ii)&nbsp;if the Independent Investment Banker obtains fewer than four such
Reference Treasury Dealer Quotations, the average of all such Reference Treasury Dealer Quotations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Independent Investment
Banker</B>&#148; means Barclays Capital Inc. or, if such firm is unwilling or unable to select the applicable Comparable Treasury Issue, an independent investment banking institution of national standing appointed by the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Reference Treasury Dealer</B>&#148; means (i)&nbsp;Barclays Capital Inc., Goldman
Sachs&nbsp;&amp; Co. LLC and J.P. Morgan Securities LLC and their respective successors; <I>provided</I>, <I>however</I>, that if any of the foregoing shall cease to be a primary United States government securities dealer in New York City (a
&#147;<B>Primary Treasury Dealer</B>&#148;), the Company shall substitute therefor another Primary Treasury Dealer and (ii)&nbsp;any other Primary Treasury Dealer selected by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Reference Treasury Dealer Quotations</B>&#148; means, with respect to each Reference Treasury Dealer and any redemption date, the
average, as determined by the Independent Investment Banker, of the bid and asked prices for the Comparable Treasury Issue for the Notes (expressed in each case as a percentage of its aggregate principal amount) quoted in writing to the Independent
Investment Banker by such Reference Treasury Dealer at 5:00&nbsp;p.m., New York City time, on the third business day preceding such redemption date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Treasury Yield</B>&#148; means, with respect to any redemption date, the rate per annum equal to the semiannual equivalent yield to
maturity of the Comparable Treasury Issue, assuming a price for the Comparable Treasury Issue (expressed as a percentage of its aggregate principal amount) equal to the applicable Comparable Treasury Price for such redemption date. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Notice of Optional Redemption </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notice of redemption shall be transmitted by the Company (or, at the Company&#146;s request, by the Trustee on the Company&#146;s behalf) to
each Holder of Notes to be redeemed. Notes in denominations larger than $2,000 may be redeemed in part but only in whole multiples of $1,000. If money sufficient to pay the redemption price of and accrued interest on all Notes (or portions thereof)
to be redeemed on the redemption date is deposited with the Paying Agent on or before the redemption date and certain other conditions are satisfied, on and after such date interest ceases to accrue on such Notes (or such portions thereof) called
for redemption. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Repurchase of the Notes Upon a Change of Control Triggering Event </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a Change of Control Triggering Event (as defined below) occurs, Holders of the Notes will have the right to require the Company to
repurchase all or any part (in integral multiples of $1,000 original principal amount) of their Notes pursuant to the offer described below (&#147;<B>Change of Control Offer</B>&#148;) on the terms set forth in this Note. In the Change of Control
Offer, the Company will be required to offer payment in cash equal to 101% of the aggregate principal amount of Notes repurchased plus accrued and unpaid interest, if any, on the Notes repurchased, to, but excluding, the date of purchase
(&#147;<B>Change of Control Payment</B>&#148;). Within 30 days following any Change of Control Triggering Event, the Company will be required to mail a notice to Holders of Notes describing the transaction or transactions that constitute the Change
of Control Triggering Event and offering to repurchase the Notes on the date specified in the notice, which date will be no earlier than 30 days and no later than 60 days from the date such notice is mailed (&#147;<B>Change of Control Payment
Date</B>&#148;), pursuant to the procedures required by the Notes and described in such notice. The Company must comply with the requirements of Rule <FONT STYLE="white-space:nowrap">14e-1</FONT> under the Exchange Act and any other securities laws
and regulations thereunder to the extent those laws and regulations are applicable in connection with the repurchase of the Notes as a result of a Change of Control Triggering Event. To the extent that the provisions of any securities laws or
regulations conflict with the Change of Control provisions of the Notes, the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Company will be required to comply with the applicable securities laws and regulations and will not be deemed to have breached its obligations under the Change of Control provisions of the Notes
by virtue of such conflicts and compliance with law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On the Change of Control Payment Date, the Company will be required, to the extent
lawful, to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">accept for payment all Notes properly tendered pursuant to the Change of Control Offer; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">deposit with the Paying Agent an amount equal to the Change of Control Payment in respect of all Notes or
portions of Notes properly tendered; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">deliver or cause to be delivered to the Trustee the Notes properly accepted together with an Officers&#146;
Certificate stating the aggregate principal amount of Notes or portions of Notes being purchased. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will not
be required to make a Change of Control Offer upon the occurrence of a Change of Control Triggering Event if a third party makes such an offer in the manner, at the times and otherwise in compliance with the requirements for an offer made by the
Company and the third party repurchases all Notes properly tendered and not withdrawn under its offer. In addition, the Company will not repurchase any Notes if there has occurred and is continuing on the Change of Control Payment Date an event of
default under the Indenture, other than a default in the payment of the Change of Control Payment upon a Change of Control Triggering Event. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of the foregoing, the following definitions are applicable: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Below Investment Grade Rating Event</B>&#148; means that the Notes are rated below an Investment Grade Rating by each of the Rating
Agencies (as defined below) on any date from the date of the public notice of an arrangement that could result in a Change of Control until the end of the <FONT STYLE="white-space:nowrap">60-day</FONT> period following public notice of the
occurrence of the Change of Control (which <FONT STYLE="white-space:nowrap">60-day</FONT> period shall be extended so long as the rating of the Notes is under publicly announced consideration for possible downgrade by any of the Rating Agencies);
<I>provided</I>, <I>however</I>, that a Below Investment Grade Rating Event otherwise arising by virtue of a particular reduction in rating will not be deemed to have occurred in respect of a particular Change of Control (and thus will not be deemed
a Below Investment Grade Rating Event for purposes of the definition of Change of Control Triggering Event) if the Rating Agencies making the reduction in rating to which this definition would otherwise apply do not announce or publicly confirm or
inform the Trustee in writing at the Company&#146;s or the Trustee&#146;s request that the reduction was the result, in whole or in part, of any event or circumstance comprised of or arising as a result of, or in respect of, the applicable Change of
Control (whether or not the applicable Change of Control has occurred at the time of the Below Investment Grade Rating Event). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Change of Control</B>&#148; means the occurrence of any of the following: (1)&nbsp;any event requiring the filing of any report under
or in response to Schedule 13D or <FONT STYLE="white-space:nowrap">14D-1</FONT> pursuant to the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Securities Exchange Act of 1934, as amended (the &#147;<B>Exchange Act</B>&#148;) disclosing beneficial ownership of either 50% or more of the Company&#146;s common stock then outstanding or 50%
or more of its voting power or its voting stock then outstanding; (2)&nbsp;the direct or indirect sale, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or a series of related transactions, of all or
substantially all of the properties or the Company&#146;s assets and the assets of its respective subsidiaries taken as a whole to one or more persons (as defined in the Indenture) other than the Company or one of its subsidiaries; or (3)&nbsp;the
first day on which a majority of the members of the Company&#146;s Board of Directors are not Continuing Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the
foregoing, a transaction will not be deemed to involve a Change of Control if (1)&nbsp;the Company becomes a direct or indirect wholly-owned subsidiary of a holding company and (2)(A) the direct or indirect holders of the voting stock of such
holding company immediately following that transaction are substantially the same as the holders of the Company&#146;s voting stock immediately prior to that transaction or (B)&nbsp;immediately following that transaction no person (other than a
holding company satisfying the requirements of this sentence) is the beneficial owner, directly or indirectly, of more than 50% of the voting stock of such holding company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Change of Control Triggering Event</B>&#148; means the occurrence of both a Change of Control and a Below Investment Grade Rating
Event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Continuing Director</B>&#148; means, as of any date of determination, any member of the Company&#146;s Board of Directors
who (1)&nbsp;was a member of such Board of Directors on the date of the issuance of the Notes; or (2)&nbsp;was nominated for election or elected to such Board of Directors with the approval of a majority of the Continuing Directors who were members
of such Board of Directors at the time of such nomination or election (either by a specific vote or by approval of the Company&#146;s proxy statement in which such member was named as a nominee for election as a director, without objection to such
nomination). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Investment Grade Rating</B>&#148; means a rating equal to or higher than Baa3 (or the equivalent) by Moody&#146;s
and <FONT STYLE="white-space:nowrap">BBB-</FONT> (or the equivalent) by S&amp;P. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Moody&#146;s</B>&#148; means Moody&#146;s
Investors Service, Inc., or its successor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Rating Agencies</B>&#148; means (1)&nbsp;each of Moody&#146;s and S&amp;P; and
(2)&nbsp;if any of Moody&#146;s or S&amp;P ceases to rate the Notes or fails to make a rating of the Notes publicly available for reasons outside of the Company&#146;s control, a &#147;nationally recognized statistical rating organization&#148;
within the meaning of Rule 3(a)(62) under the Exchange Act selected by the Company (as certified by a resolution of the Company&#146;s Board of Directors) as a replacement agency for Moody&#146;s or S&amp;P, or both of them, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>S&amp;P</B>&#148; means S&amp;P Global Ratings, a division of S&amp;P Global Inc., or its successor. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Denominations; Transfer; Exchange </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes are in registered form without coupons in denominations of $2,000 and integral multiples of $1,000 in excess thereof. Holders of
Notes may transfer or exchange Notes </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
in accordance with the Indenture. The Registrar may require a Holder of Notes, among other things, to furnish appropriate endorsements or transfer documents and to pay any taxes and fees required
by law or permitted by the Indenture. The Registrar need not register the transfer of or exchange any Notes selected for redemption (except, in the case of a Note to be redeemed in part, the portion of the Note not to be redeemed) or any Notes for a
period of 15&nbsp;days before a selection of Notes to be redeemed or 15&nbsp;days before an interest payment date. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Persons Deemed Owners </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The registered Holder of this Note may be treated as the sole owner of such Note for all purposes. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(j)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Unclaimed Money </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to applicable abandoned property law, if money for the payment of principal or interest remains unclaimed for two years, the Trustee or
Paying Agent shall pay the money back to the Company at its request unless an abandoned property law designates another Person. After any such payment, Holders entitled to the money must look only to the Company and not to the Trustee or Paying
Agent for payment. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(k)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Discharge and Defeasance </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain conditions, the Company at any time may terminate some or all of its obligations under the Notes and the Indenture if the
Company deposits with the Trustee money or U.S. Government Obligations for the payment of principal and interest on the Notes to redemption or maturity, as the case may be. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(l)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Amendment; Waiver </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain exceptions set forth in the Indenture, (i)&nbsp;the Indenture or the Notes may be amended with the written consent of the
Holders of at least a majority in principal amount outstanding of the Notes; and (ii)&nbsp;any default or compliance with any provision may be waived with the written consent of the Holders of a majority in principal amount of the Notes then
outstanding. Subject to certain exceptions set forth in the Indenture, without the consent of any Holder of a Note, the Company and the Trustee may amend the Indenture or the Notes to cure any ambiguity, omission, defect or inconsistency that does
not materially and adversely affect the rights of any Holder of a Note, or to comply with Article&nbsp;5 of the Indenture or to comply with requirements of the SEC in connection with the qualification of the Indenture under the TIA. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(m)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Defaults and Remedies </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If an Event of Default occurs and is continuing, the Trustee or the Holders of at least 25% in aggregate principal amount of the Notes may
declare all the Notes to be due and payable immediately. Certain events of bankruptcy or insolvency are Events of Default which will result in the Notes being due and payable immediately upon the occurrence of such Events of Default. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Holders of Notes may not enforce the Indenture or the Notes except as provided in the Indenture. The Trustee may refuse to enforce the
Indenture or the Notes unless it receives </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
indemnity or security satisfactory to it. Subject to certain limitations, Holders of a majority in principal amount of the Notes may direct the Trustee in its exercise of any trust or power. The
Trustee may withhold from Holders of Notes notice of any continuing Default (except a Default in payment of principal or interest) if it determines that withholding such notice is in the interest of the Holders of Notes. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(n)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Trustee Dealings with the Company </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain limitations imposed by the TIA, the Trustee under the Indenture, in its individual or any other capacity, may become the
owner or pledgee of Notes and may otherwise deal with and collect obligations owed to it by the Company or its Affiliates and may otherwise deal with the Company or its Affiliates with the same rights it would have if it were not Trustee. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(o)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No Recourse Against Others </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A director, officer, employee or stockholder, as such, of the Company or the Trustee shall not have any liability for any obligations of the
Company under the Notes or the Indenture or for any claim based on, in respect of or by reason of such obligations. By accepting a Note, each Holder of a Note waives and releases all such liability. The waiver and release are part of the
consideration for the issue of the Notes. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(p)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Authentication </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note shall not be valid until an authorized signatory of the Trustee (or an authenticating agent) manually signs the certificate of
authentication on the face of this Note. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(q)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Abbreviations </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Customary abbreviations may be used in the name of a Holder of a Note or an assignee, such as TEN COM (=tenants in common), TEN ENT (=tenants
by the entireties), JT TEN (=joint tenants with rights of survivorship and not as tenants in common), CUST (=custodian), and U/G/M/A (=Uniform Gift to Minors Act). </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(r)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Governing Law </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note shall be governed by, and construed in accordance with, the laws of the State of New York. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(s)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">CUSIP Numbers </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the recommendation promulgated by the Committee on Uniform Security Identification Procedures, the Company has caused CUSIP numbers
to be printed on the Notes and has directed the Trustee to use such CUSIP numbers in notices of redemption as a convenience to Holders of Notes. No representation is made as to the accuracy of such numbers either as printed on the Notes or as
contained in any notice of redemption and reliance may be placed only on the other identification numbers placed thereon. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will furnish to any Holder of a Note upon written request and without charge to
such Holder of a Note a copy of the Indenture. Requests may be made to: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CVS Health Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">One CVS Drive &#151; MC 1008 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Woonsocket, Rhode Island 02895 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention: Valerie Haertel </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Terms
defined in the Indenture and not otherwise defined herein are used herein as therein defined. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ASSIGNMENT FORM </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">To assign this Note, complete the form below: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">I or we assign and transfer this Note to: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Print or type assignee&#146;s name, address and zip code] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Insert assignee&#146;s soc. sec. or tax I.D. No.] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">and irrevocably appoint
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> as agent to </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">transfer this Note on the books of CVS Health Corporation. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The agent may substitute another to act for him. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="42%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="39%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Date:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Your&nbsp;Signature:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sign exactly as your name appears on the face of this Note. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>4
<FILENAME>d791446dex43.htm
<DESCRIPTION>EX-4.3
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.3 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY (&#147;DTC&#148;), TO THE COMPANY OR ITS
AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE&nbsp;&amp; CO. OR SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO
CEDE&nbsp;&amp; CO., OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF,
CEDE&nbsp;&amp; CO., HAS AN INTEREST HEREIN. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">UNLESS AND UNTIL THIS GLOBAL NOTE IS EXCHANGED IN WHOLE OR IN PART FOR A GLOBAL NOTE IN
DEFINITIVE REGISTERED FORM, THIS GLOBAL NOTE MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY DTC TO A NOMINEE OF DTC OR BY A NOMINEE OF DTC TO DTC OR ANOTHER NOMINEE OF DTC OR BY DTC OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH
SUCCESSOR DEPOSITARY. </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CVS HEALTH CORPORATION </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">No.&nbsp;[&#9679;]</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">$[&#9679;]</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CUSIP No.&nbsp;126650 DG2 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ISIN
No.&nbsp;US126650DG21 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3.250% Senior Note due 2029 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">CVS HEALTH CORPORATION, a Delaware corporation (such corporation, and its successors and assigns under the Indenture hereinafter referred to,
being herein called the &#147;<B>Company</B>&#148;), for value received promises to pay to CEDE&nbsp;&amp; CO., or registered assigns, the principal sum of $[&#149;] on August&nbsp;15, 2029. If such maturity date is not a Business Day, then payment
of principal will be made on the next succeeding Business Day and no interest will accrue on the amount so payable for the period from such maturity date to the date payment is made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest Payment Dates: February&nbsp;15 and August 15. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Record Dates: Each February&nbsp;1 and August&nbsp;1, immediately preceding each Interest Payment Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additional provisions of this Note are set forth on the reverse side of this Note. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Remainder of page intentionally left blank]</I> </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Company has caused this Note to be duly executed. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>CVS HEALTH CORPORATION</B></TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Note No. [</I><I></I>&#9679;<I></I><I></I><I>] of 2029 Notes</I>] </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: August&nbsp;15, 2019 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TRUSTEE&#146;S CERTIFICATE OF AUTHENTICATION </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THE BANK OF NEW
YORK MELLON TRUST COMPANY, N.A., </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">as Trustee, certifies that this is one of the Debt Securities referred to </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">in the Indenture. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Authorized Signatory</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Note No. [</I><I></I>&#9679;<I></I><I></I><I>] of 2029 Notes</I>] </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3.250% Senior Note due 2029 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note is one of a duly authorized series of Notes of CVS Health Corporation, a Delaware corporation (such corporation, and its successors
and assigns under the Indenture hereinafter referred to, being herein called the &#147;<B>Company</B>&#148;), designated as its 3.250% Senior Notes due 2029 (hereinafter referred to as the &#147;<B>Notes</B>&#148;). </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Interest </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company promises to pay interest on the principal amount of this Note at the rate per annum shown above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will pay interest on the Notes semi-annually on February&nbsp;15 and August&nbsp;15 of each year, commencing February&nbsp;15,
2020. Interest on the Notes will accrue from the most recent date to which interest has been paid or provided for, or, if no interest has been paid or provided for, from August&nbsp;15, 2019. Interest will be computed on the basis of a <FONT
STYLE="white-space:nowrap">360-day</FONT> year of twelve <FONT STYLE="white-space:nowrap">30-day&nbsp;months.</FONT> The Company shall pay interest on overdue principal at the rate borne by the Notes. If any interest payment date is not a Business
Day, then payment of interest will be made on the next succeeding Business Day and no interest will accrue on the amount so payable for the period from such interest payment date to the date payment is made. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Method of Payment </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will pay interest on the Notes (except defaulted interest) to the Persons who are registered Holders thereof at the close of
business on the February&nbsp;1 and August&nbsp;1 (whether or not a Business Day) immediately preceding the interest payment date even if the Notes are canceled after the record date and on or before the interest payment date. Holders must surrender
Notes to a Paying Agent to collect principal payments. The Company will pay principal, premium, if any, and interest in money of the United States that at the time of payment is legal tender for payment of public and private debts by wire transfer
of immediately available funds to the accounts specified by the Holders, or, if no such account is specified, the Company may pay principal and interest by check payable in such money. It may mail an interest check to a Holder&#146;s registered
address. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Paying Agent and Registrar </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Initially, The Bank of New York Mellon Trust Company, N.A., a national banking association (the &#147;<B>Trustee</B>&#148;), will act as Paying
Agent and Registrar. The Company may appoint and change any Paying Agent, Registrar or <FONT STYLE="white-space:nowrap">co-registrar</FONT> without notice. The Company or any of its domestically incorporated Wholly Owned Subsidiaries may act as
Paying Agent, Registrar or <FONT STYLE="white-space:nowrap">co-registrar.</FONT> </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Indenture </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company issued the Notes under an Indenture dated as of August&nbsp;15, 2006 (the &#147;<B>Indenture</B>&#148;), between the Company and
the Trustee. The terms of the Notes include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939 (15 U.S.C. ss.ss. 77aaa-77bbbb) as in effect on the date of the Indenture (the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
&#147;<B>TIA</B>&#148;). Terms defined in the Indenture and not defined herein have the meanings ascribed thereto in the Indenture. The Notes are subject to all such terms, and Holders of Notes
are referred to the Indenture and the TIA for a statement of those terms. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes are general unsecured senior obligations of the
Company initially limited to $1,750,000,000 aggregate principal amount (subject to Section&nbsp;2.08 of the Indenture). The Company may at any time issue additional Notes under the Indenture in unlimited amounts having the same terms as and treated
as a single class with the Notes for all purposes under the Indenture and will vote together as one class with respect to the Notes. The Indenture imposes certain limitations on the incurrence of certain additional indebtedness by the Company and
certain of its subsidiaries and the entry into certain sale and leaseback arrangements by the Company and certain of its subsidiaries. The Indenture also restricts the ability of the Company to consolidate or merge with or into, or to transfer all
or substantially all its assets to, another person. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Optional Redemption </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to May&nbsp;15, 2029, the Company, at its option, may at any time redeem all or any portion of the Notes upon not less than 15 nor more
than 60 days&#146; notice, at a redemption price, plus accrued and unpaid interest, if any, to, but excluding, the redemption date, equal to the greater of (i)&nbsp;100% of the aggregate principal amount of the Notes being redeemed or (ii)&nbsp;the
sum of the present values of the remaining scheduled payments of principal and interest on the Notes being redeemed (not including any portion of such payments of interest accrued to the redemption date) discounted to the redemption date on a
semiannual basis (assuming a <FONT STYLE="white-space:nowrap">360-day</FONT> year consisting of twelve <FONT STYLE="white-space:nowrap">30-day&nbsp;months)</FONT> at the applicable Treasury Yield plus 25 basis points. If any redemption date is not a
Business Day, then payment of the redemption price and accrued and unpaid interest will be made on the next succeeding Business Day, and no interest will accrue on the amounts so payable for the period from such redemption date to the date payment
is made. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Comparable Treasury Issue</B>&#148; means the United States Treasury security selected by an Independent Investment
Banker as having a maturity comparable to the remaining term of the Notes that would be utilized, at the time of selection and in accordance with customary financial practice, in pricing new issues of corporate debt securities of comparable maturity
to such remaining term. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Comparable Treasury Price</B>&#148; means, with respect to any redemption date, (i)&nbsp;the average of
the applicable Reference Treasury Dealer Quotations for such redemption date, after excluding the highest and lowest such applicable Reference Treasury Dealer Quotations, or (ii)&nbsp;if the Independent Investment Banker obtains fewer than four such
Reference Treasury Dealer Quotations, the average of all such Reference Treasury Dealer Quotations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Independent Investment
Banker</B>&#148; means Barclays Capital Inc. or, if such firm is unwilling or unable to select the applicable Comparable Treasury Issue, an independent investment banking institution of national standing appointed by the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Reference Treasury Dealer</B>&#148; means (i)&nbsp;Barclays Capital Inc., Goldman
Sachs&nbsp;&amp; Co. LLC and J.P. Morgan Securities LLC and their respective successors; <I>provided</I>, <I>however</I>, that if any of the foregoing shall cease to be a primary United States government securities dealer in New York City (a
&#147;<B>Primary Treasury Dealer</B>&#148;), the Company shall substitute therefor another Primary Treasury Dealer and (ii)&nbsp;any other Primary Treasury Dealer selected by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Reference Treasury Dealer Quotations</B>&#148; means, with respect to each Reference Treasury Dealer and any redemption date, the
average, as determined by the Independent Investment Banker, of the bid and asked prices for the Comparable Treasury Issue for the Notes (expressed in each case as a percentage of its aggregate principal amount) quoted in writing to the Independent
Investment Banker by such Reference Treasury Dealer at 5:00&nbsp;p.m., New York City time, on the third business day preceding such redemption date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Treasury Yield</B>&#148; means, with respect to any redemption date, the rate per annum equal to the semiannual equivalent yield to
maturity of the Comparable Treasury Issue, assuming a price for the Comparable Treasury Issue (expressed as a percentage of its aggregate principal amount) equal to the applicable Comparable Treasury Price for such redemption date. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Notice of Optional Redemption </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notice of redemption shall be transmitted by the Company (or, at the Company&#146;s request, by the Trustee on the Company&#146;s behalf) to
each Holder of Notes to be redeemed. Notes in denominations larger than $2,000 may be redeemed in part but only in whole multiples of $1,000. If money sufficient to pay the redemption price of and accrued interest on all Notes (or portions thereof)
to be redeemed on the redemption date is deposited with the Paying Agent on or before the redemption date and certain other conditions are satisfied, on and after such date interest ceases to accrue on such Notes (or such portions thereof) called
for redemption. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Repurchase of the Notes Upon a Change of Control Triggering Event </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a Change of Control Triggering Event (as defined below) occurs, Holders of the Notes will have the right to require the Company to
repurchase all or any part (in integral multiples of $1,000 original principal amount) of their Notes pursuant to the offer described below (&#147;<B>Change of Control Offer</B>&#148;) on the terms set forth in this Note. In the Change of Control
Offer, the Company will be required to offer payment in cash equal to 101% of the aggregate principal amount of Notes repurchased plus accrued and unpaid interest, if any, on the Notes repurchased, to, but excluding, the date of purchase
(&#147;<B>Change of Control Payment</B>&#148;). Within 30 days following any Change of Control Triggering Event, the Company will be required to mail a notice to Holders of Notes describing the transaction or transactions that constitute the Change
of Control Triggering Event and offering to repurchase the Notes on the date specified in the notice, which date will be no earlier than 30 days and no later than 60 days from the date such notice is mailed (&#147;<B>Change of Control Payment
Date</B>&#148;), pursuant to the procedures required by the Notes and described in such notice. The Company must comply with the requirements of Rule <FONT STYLE="white-space:nowrap">14e-1</FONT> under the Exchange Act and any other securities laws
and regulations thereunder to the extent those laws and regulations are applicable in connection with the repurchase of the Notes as a result of a Change of Control Triggering Event. To the extent that the provisions of any securities laws or
regulations conflict with the Change of Control provisions of the Notes, the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Company will be required to comply with the applicable securities laws and regulations and will not be deemed to have breached its obligations under the Change of Control provisions of the Notes
by virtue of such conflicts and compliance with law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On the Change of Control Payment Date, the Company will be required, to the extent
lawful, to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">accept for payment all Notes properly tendered pursuant to the Change of Control Offer; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">deposit with the Paying Agent an amount equal to the Change of Control Payment in respect of all Notes or
portions of Notes properly tendered; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">deliver or cause to be delivered to the Trustee the Notes properly accepted together with an Officers&#146;
Certificate stating the aggregate principal amount of Notes or portions of Notes being purchased. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will not
be required to make a Change of Control Offer upon the occurrence of a Change of Control Triggering Event if a third party makes such an offer in the manner, at the times and otherwise in compliance with the requirements for an offer made by the
Company and the third party repurchases all Notes properly tendered and not withdrawn under its offer. In addition, the Company will not repurchase any Notes if there has occurred and is continuing on the Change of Control Payment Date an event of
default under the Indenture, other than a default in the payment of the Change of Control Payment upon a Change of Control Triggering Event. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of the foregoing, the following definitions are applicable: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Below Investment Grade Rating Event</B>&#148; means that the Notes are rated below an Investment Grade Rating by each of the Rating
Agencies (as defined below) on any date from the date of the public notice of an arrangement that could result in a Change of Control until the end of the <FONT STYLE="white-space:nowrap">60-day</FONT> period following public notice of the
occurrence of the Change of Control (which <FONT STYLE="white-space:nowrap">60-day</FONT> period shall be extended so long as the rating of the Notes is under publicly announced consideration for possible downgrade by any of the Rating Agencies);
<I>provided</I>, <I>however</I>, that a Below Investment Grade Rating Event otherwise arising by virtue of a particular reduction in rating will not be deemed to have occurred in respect of a particular Change of Control (and thus will not be deemed
a Below Investment Grade Rating Event for purposes of the definition of Change of Control Triggering Event) if the Rating Agencies making the reduction in rating to which this definition would otherwise apply do not announce or publicly confirm or
inform the Trustee in writing at the Company&#146;s or the Trustee&#146;s request that the reduction was the result, in whole or in part, of any event or circumstance comprised of or arising as a result of, or in respect of, the applicable Change of
Control (whether or not the applicable Change of Control has occurred at the time of the Below Investment Grade Rating Event). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Change of Control</B>&#148; means the occurrence of any of the following: (1)&nbsp;any event requiring the filing of any report under
or in response to Schedule 13D or <FONT STYLE="white-space:nowrap">14D-1</FONT> pursuant to the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Securities Exchange Act of 1934, as amended (the &#147;<B>Exchange Act</B>&#148;) disclosing beneficial ownership of either 50% or more of the Company&#146;s common stock then outstanding or 50%
or more of its voting power or its voting stock then outstanding; (2)&nbsp;the direct or indirect sale, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or a series of related transactions, of all or
substantially all of the properties or the Company&#146;s assets and the assets of its respective subsidiaries taken as a whole to one or more persons (as defined in the Indenture) other than the Company or one of its subsidiaries; or (3)&nbsp;the
first day on which a majority of the members of the Company&#146;s Board of Directors are not Continuing Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the
foregoing, a transaction will not be deemed to involve a Change of Control if (1)&nbsp;the Company becomes a direct or indirect wholly-owned subsidiary of a holding company and (2)(A) the direct or indirect holders of the voting stock of such
holding company immediately following that transaction are substantially the same as the holders of the Company&#146;s voting stock immediately prior to that transaction or (B)&nbsp;immediately following that transaction no person (other than a
holding company satisfying the requirements of this sentence) is the beneficial owner, directly or indirectly, of more than 50% of the voting stock of such holding company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Change of Control Triggering Event</B>&#148; means the occurrence of both a Change of Control and a Below Investment Grade Rating
Event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Continuing Director</B>&#148; means, as of any date of determination, any member of the Company&#146;s Board of Directors
who (1)&nbsp;was a member of such Board of Directors on the date of the issuance of the Notes; or (2)&nbsp;was nominated for election or elected to such Board of Directors with the approval of a majority of the Continuing Directors who were members
of such Board of Directors at the time of such nomination or election (either by a specific vote or by approval of the Company&#146;s proxy statement in which such member was named as a nominee for election as a director, without objection to such
nomination). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Investment Grade Rating</B>&#148; means a rating equal to or higher than Baa3 (or the equivalent) by Moody&#146;s
and <FONT STYLE="white-space:nowrap">BBB-</FONT> (or the equivalent) by S&amp;P. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Moody&#146;s</B>&#148; means Moody&#146;s
Investors Service, Inc., or its successor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Rating Agencies</B>&#148; means (1)&nbsp;each of Moody&#146;s and S&amp;P; and
(2)&nbsp;if any of Moody&#146;s or S&amp;P ceases to rate the Notes or fails to make a rating of the Notes publicly available for reasons outside of the Company&#146;s control, a &#147;nationally recognized statistical rating organization&#148;
within the meaning of Rule 3(a)(62) under the Exchange Act selected by the Company (as certified by a resolution of the Company&#146;s Board of Directors) as a replacement agency for Moody&#146;s or S&amp;P, or both of them, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>S&amp;P</B>&#148; means S&amp;P Global Ratings, a division of S&amp;P Global Inc., or its successor. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Denominations; Transfer; Exchange </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes are in registered form without coupons in denominations of $2,000 and integral multiples of $1,000 in excess thereof. Holders of
Notes may transfer or exchange Notes </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
in accordance with the Indenture. The Registrar may require a Holder of Notes, among other things, to furnish appropriate endorsements or transfer documents and to pay any taxes and fees required
by law or permitted by the Indenture. The Registrar need not register the transfer of or exchange any Notes selected for redemption (except, in the case of a Note to be redeemed in part, the portion of the Note not to be redeemed) or any Notes for a
period of 15&nbsp;days before a selection of Notes to be redeemed or 15&nbsp;days before an interest payment date. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Persons Deemed Owners </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The registered Holder of this Note may be treated as the sole owner of such Note for all purposes. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(j)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Unclaimed Money </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to applicable abandoned property law, if money for the payment of principal or interest remains unclaimed for two years, the Trustee or
Paying Agent shall pay the money back to the Company at its request unless an abandoned property law designates another Person. After any such payment, Holders entitled to the money must look only to the Company and not to the Trustee or Paying
Agent for payment. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(k)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Discharge and Defeasance </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain conditions, the Company at any time may terminate some or all of its obligations under the Notes and the Indenture if the
Company deposits with the Trustee money or U.S. Government Obligations for the payment of principal and interest on the Notes to redemption or maturity, as the case may be. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(l)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Amendment; Waiver </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain exceptions set forth in the Indenture, (i)&nbsp;the Indenture or the Notes may be amended with the written consent of the
Holders of at least a majority in principal amount outstanding of the Notes; and (ii)&nbsp;any default or compliance with any provision may be waived with the written consent of the Holders of a majority in principal amount of the Notes then
outstanding. Subject to certain exceptions set forth in the Indenture, without the consent of any Holder of a Note, the Company and the Trustee may amend the Indenture or the Notes to cure any ambiguity, omission, defect or inconsistency that does
not materially and adversely affect the rights of any Holder of a Note, or to comply with Article&nbsp;5 of the Indenture or to comply with requirements of the SEC in connection with the qualification of the Indenture under the TIA. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(m)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Defaults and Remedies </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If an Event of Default occurs and is continuing, the Trustee or the Holders of at least 25% in aggregate principal amount of the Notes may
declare all the Notes to be due and payable immediately. Certain events of bankruptcy or insolvency are Events of Default which will result in the Notes being due and payable immediately upon the occurrence of such Events of Default. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Holders of Notes may not enforce the Indenture or the Notes except as provided in the
Indenture. The Trustee may refuse to enforce the Indenture or the Notes unless it receives indemnity or security satisfactory to it. Subject to certain limitations, Holders of a majority in principal amount of the Notes may direct the Trustee in its
exercise of any trust or power. The Trustee may withhold from Holders of Notes notice of any continuing Default (except a Default in payment of principal or interest) if it determines that withholding such notice is in the interest of the Holders of
Notes. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(n)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Trustee Dealings with the Company </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain limitations imposed by the TIA, the Trustee under the Indenture, in its individual or any other capacity, may become the
owner or pledgee of Notes and may otherwise deal with and collect obligations owed to it by the Company or its Affiliates and may otherwise deal with the Company or its Affiliates with the same rights it would have if it were not Trustee. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(o)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No Recourse Against Others </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A director, officer, employee or stockholder, as such, of the Company or the Trustee shall not have any liability for any obligations of the
Company under the Notes or the Indenture or for any claim based on, in respect of or by reason of such obligations. By accepting a Note, each Holder of a Note waives and releases all such liability. The waiver and release are part of the
consideration for the issue of the Notes. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(p)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Authentication </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note shall not be valid until an authorized signatory of the Trustee (or an authenticating agent) manually signs the certificate of
authentication on the face of this Note. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(q)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Abbreviations </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Customary abbreviations may be used in the name of a Holder of a Note or an assignee, such as TEN COM (=tenants in common), TEN ENT (=tenants
by the entireties), JT TEN (=joint tenants with rights of survivorship and not as tenants in common), CUST (=custodian), and U/G/M/A (=Uniform Gift to Minors Act). </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(r)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Governing Law </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note shall be governed by, and construed in accordance with, the laws of the State of New York. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(s)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">CUSIP Numbers </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the recommendation promulgated by the Committee on Uniform Security Identification Procedures, the Company has caused CUSIP numbers
to be printed on the Notes and has directed the Trustee to use such CUSIP numbers in notices of redemption as a convenience to Holders of Notes. No representation is made as to the accuracy of such numbers either as printed on the Notes or as
contained in any notice of redemption and reliance may be placed only on the other identification numbers placed thereon. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will furnish to any Holder of a Note upon written request and without charge to
such Holder of a Note a copy of the Indenture. Requests may be made to: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CVS Health Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">One CVS Drive &#151; MC 1008 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Woonsocket, Rhode Island 02895 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention: Valerie Haertel </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Terms
defined in the Indenture and not otherwise defined herein are used herein as therein defined. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ASSIGNMENT FORM </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">To assign this Note, complete the form below: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">I or we assign and transfer this Note to: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Print or type assignee&#146;s name, address and zip code] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Insert assignee&#146;s soc. sec. or tax I.D. No.] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">and irrevocably appoint
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> as agent to </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">transfer this Note on the books of CVS Health Corporation. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The agent may substitute another to act for him. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="42%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="39%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Date:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Your&nbsp;Signature:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sign exactly as your name appears on the face of this Note. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>5
<FILENAME>d791446dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g791446g70l27.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">599 Lexington Avenue </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">New York, NY 10022-6069 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">+1.212.848.4000 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">August&nbsp;15,
2019 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CVS Health Corporation </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">One CVS Drive </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Woonsocket, RI 02895 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CVS Health Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>$1,000,000,000 2.625% Senior Notes due 2024 </U></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>$750,000,000 3.000% Senior Notes due 2026 </U></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>$1,750,000,000 3.250% Senior Notes due 2029 </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have acted as counsel to CVS Health
Corporation, a Delaware corporation (the &#147;<U>Company</U>&#148;), in connection with the issuance and sale by the Company of $1,000,000,000 aggregate principal amount of the Company&#146;s 2.625% Senior Notes due 2024 (the &#147;<U>2024
Notes</U>&#148;), $750,000,000 aggregate principal amount of the Company&#146;s 3.000% Senior Notes due 2026 (the &#147;<U>2026 Notes</U>&#148;), $1,750,000,000 aggregate principal amount of the Company&#146;s 3.250% Senior Notes due 2029 (the
&#147;<U>2029 Notes</U>&#148; and together with the 2024 Notes and 2026 Notes, the &#147;<U>Notes</U>&#148;) pursuant to the Underwriting Agreement, dated August&nbsp;8, 2019 (the &#147;<U>Underwriting Agreement</U>&#148;), among the Company and the
underwriters named therein. The Notes will be issued pursuant to an indenture, dated as of August&nbsp;15, 2006 (the &#147;<U>Indenture</U>&#148;), between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee (the
&#147;<U>Trustee</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In that connection, we have reviewed originals or copies of the following documents: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Underwriting Agreement; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Indenture; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Executive Officers&#146; Certificate pursuant to the Indenture dated August&nbsp;15, 2019; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Notes in global form as executed by the Company. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The documents described in the foregoing clauses (a)&nbsp;through (d) are collectively referred to herein as the &#147;<U>Opinion Documents</U>&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In our review of the Opinion Documents, we have assumed: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The genuineness of all signatures. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The authenticity of the originals of the documents submitted to us. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The conformity to authentic originals of any documents submitted to us as copies. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SHEARMAN.COM </B></P>
<P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Shearman&nbsp;&amp; Sterling LLP is a limited liability partnership organized in the United States under the laws of the state of Delaware, which laws limit the
personal liability of partners. </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">As to matters of fact, the truthfulness of the representations made in the Underwriting Agreement and the other
Opinion Documents and in certificates of public officials and officers of the Company. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">That each of the Opinion Documents is the legal, valid and binding obligation of each party thereto, other than
the Company, enforceable against each such party in accordance with its terms. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">That the execution, delivery and performance by the Company of the Opinion Documents to which it is a party do
not and will not, except with respect to Generally Applicable Law, violate any law, rule or regulation applicable to it. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">That the execution, delivery and performance by the Company of the Opinion Documents to which it is a party do
not and will not result in any conflict with or breach of any agreement or document binding on it. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">That, except with respect to Generally Applicable Law, no authorization, approval, consent or other action by,
and no notice to or filing with, any governmental authority or regulatory body or any other third party is required for the due execution, delivery or performance by the Company of any Opinion Document to which it is a party or, if any such
authorization, approval, consent, action, notice or filing is required, it has been duly obtained, taken, given or made and is in full force and effect. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have not independently established the validity of the foregoing assumptions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<U>Generally Applicable Law</U>&#148; means the federal law of the United States of America, and the law of the State of New&nbsp;York (including in
each case the rules or regulations promulgated thereunder or pursuant thereto), that a New&nbsp;York lawyer exercising customary professional diligence would reasonably be expected to recognize as being applicable to the Company, the Opinion
Documents or the transactions governed by the Opinion Documents, and for purposes of assumption paragraphs (f)&nbsp;and (h) above and our opinion below, the General Corporation Law of the State of Delaware. Without limiting the generality of the
foregoing definition of Generally Applicable Law, the term &#147;Generally Applicable Law&#148; does not include any law, rule or regulation that is applicable to the Company, the Opinion Documents or such transactions solely because such law, rule
or regulation is part of a regulatory regime applicable to any party to any of the Opinion Documents or any of its affiliates due to the specific assets or business of such party or such affiliate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Based upon the foregoing and upon such other investigation as we have deemed necessary and subject to the qualifications set forth below, we are of the
opinion that the Notes have been duly authorized and executed by the Company and, when authenticated by the Trustee in accordance with the Indenture and delivered and paid for as provided in the Underwriting Agreement, the Notes will be the legal,
valid and binding obligations of the Company, enforceable against the Company in accordance with their terms and entitled to the benefits of the Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our opinion expressed above is subject to the following qualifications: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Our opinion above is subject to the effect of any applicable bankruptcy, insolvency, reorganization, moratorium
or similar laws affecting creditors&#146; rights generally (including without limitation all laws relating to fraudulent transfers). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Our opinion above is also subject to the effect of general principles of equity, including without limitation
concepts of materiality, reasonableness, good faith and fair dealing (regardless of whether considered in a proceeding in equity or at law). </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Our opinion is limited to Generally Applicable Law, and we do not express any opinion herein concerning any
other law. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This opinion letter speaks only as of the date hereof. We expressly disclaim any responsibility to advise you of any
development or circumstance of any kind, including any change of law or fact, that may occur after the date of this opinion letter and which might affect the opinions expressed herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This opinion letter is rendered to you in connection with the transactions contemplated by the Opinion Documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We hereby consent to the filing of this opinion as an exhibit to the Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> to be filed
August&nbsp;15, 2019 by the Company and incorporated by reference into the Registration Statement on Form <FONT STYLE="white-space:nowrap">S-3ASR</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-217596)</FONT> filed by the Company to
effect the registration of the Notes under the Securities Act of 1933, as amended (the &#147;<U>Securities Act</U>&#148;), and to the use of our name under the heading &#147;Legal Matters&#148; in the prospectus constituting a part of such
Registration Statement. In giving such consent, we do not hereby admit that we are in the category of persons whose consent is required under Section&nbsp;7 of the Securities Act or the rules and regulations of the Securities and Exchange Commission
promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Very truly yours, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/
Shearman&nbsp;&amp; Sterling LLP </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">LN/dy/gl/nk </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">STG </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>6
<FILENAME>d791446dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g791446g0815110227022.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="43%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="42%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Investor</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Valerie Haertel</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Media</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">T.J. Crawford</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Contact:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Senior Vice President</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Contact:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Vice President</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Investor Relations</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">External Affairs</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">(401) <FONT STYLE="white-space:nowrap">770-4050</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">(212) <FONT STYLE="white-space:nowrap">457-0583</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FOR IMMEDIATE RELEASE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CVS Health Corporation Announces Expiration and Results of Any and All Tender Offers </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">WOONSOCKET, RI, August&nbsp;15, 2019 &#150; CVS Health Corporation (&#147;CVS Health&#148;, NYSE: CVS) announced today the results of the previously announced
cash tender offers (the &#147;Any and All Tender Offers&#148; and each an &#147;Any and All Tender Offer&#148;) for (1)&nbsp;any and all of its 3.125% Senior Notes due 2020 (the &#147;2020 Any and All Notes&#148;) and (2)&nbsp;any and all of its
4.125% Senior Notes due 2021, the 4.125% Senior Notes due 2021 issued by its wholly-owned subsidiary, Aetna Inc. (&#147;Aetna&#148;) and the 5.450% Senior Notes due 2021 issued by Coventry Health Care, Inc., a wholly-owned subsidiary of Aetna
(collectively, the &#147;2021 Any and All Notes&#148; and together with the 2020 Any and All Notes, the &#147;Any and All Notes&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of 5:00 p.m.,
New York City time, on August&nbsp;14, 2019 (the &#147;Any and All Expiration Date&#148;) as reported by D.F. King&nbsp;&amp; Co., Inc., the Tender and Information Agent for the Any and All Tender Offers, the principal amounts of the Any and All
Notes listed in the tables below have been validly tendered and not validly withdrawn, or tendered pursuant to the guaranteed delivery procedures (the &#147;Guaranteed Delivery Procedures&#148;) described in the Offer to Purchase dated
August&nbsp;8, 2019 (as amended or supplemented from time to time, the &#147;Offer to Purchase&#148;). In order to be eligible to participate in the Any and All Tender Offers, holders (individually, a &#147;Holder&#148; and collectively, the
&#147;Holders&#148;) of Any and All Notes tendered pursuant to the Guaranteed Delivery Procedures at or prior to the Any and All Expiration Date must deliver such Any and All Notes to CVS Health at or prior&nbsp;to&nbsp;5:00&nbsp;p.m., New York City
time, on August&nbsp;16, 2019 (the &#147;Guaranteed Delivery Deadline&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to the Any and All Tender Offers, CVS Health previously
announced its Maximum Tender Offers (as defined in the Offer to Purchase) for the Maximum Tender Offer Notes (as defined in the Offer to Purchase) concurrently with the Any and All Tender Offers. The 2020 Notes Maximum Tender Offer Amount (as
defined in the Offer to Purchase) is up to $2,000,000,000 <I>less</I> the aggregate principal amount of 2020 Any and All Notes accepted for purchase and the 2021 Notes Maximum Tender Offer Amount (as defined in the Offer to Purchase) is up to
$2,000,000,000 <I>less</I> the aggregate principal amount of 2021 Any and All Notes accepted for purchase. Because $7,530,000 aggregate principal amount of 2020 Any and All Notes and $4,905,000 aggregate principal amount of 2021 Any and All Notes
remain subject to the Guaranteed Delivery Procedures, the 2020 Notes Maximum Tender Offer Amount and 2021 Notes Maximum Tender Offer Amount are subject to change and will be confirmed after expiration of guaranteed deliveries at the Guaranteed
Delivery Deadline. Holders are urged to read the Offer to Purchase carefully before making any decision with respect to the Maximum Tender Offers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Holders of all Any and All Notes validly tendered and not validly withdrawn at or prior to the Any and All Expiration Date and accepted for purchase were
eligible to receive the applicable Total Consideration set forth in the tables below, plus accrued and unpaid interest (&#147;Accrued Interest&#148;) up to, but not including, today, August&nbsp;15, 2019, the settlement date of the Any and All
Tender Offers. For the avoidance of doubt, Accrued Interest payable with respect to Any and All Notes validly tendered pursuant to the Guaranteed Delivery Procedures and accepted for purchase shall cease to accrue on the Any and All Settlement Date.
</P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B></B><B><I>2020 Any and All Notes</I></B><B>: </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Title of Notes</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>CUSIP<BR>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Original&nbsp;Issuer</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Total<BR>Consideration<SUP
STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Principal
Amount<BR>Outstanding</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Principal
Amount<BR>Tendered</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Principal&nbsp;Amount<BR>Tendered&nbsp;Pursuant&nbsp;to<BR>Guaranteed
Delivery<BR>Procedures</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.125% Senior Notes due 2020</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">126650DA5</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">CVS&nbsp;Health&nbsp;Corporation</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$1,005.86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$2,000,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$1,269,297,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$7,530,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="20"> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B></B><B><I>2021 Any and All Notes</I></B><B>:</B></P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="top"> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt"></P> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman"><B></B><B><I></I></B><B>&nbsp;</B></P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt"></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Title of Notes</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>CUSIP<BR>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Original&nbsp;Issuer</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Total<BR>Consideration<SUP
STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Principal&nbsp;Amount<BR>Outstanding</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Principal&nbsp;Amount<BR>Tendered</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Principal&nbsp;Amount<BR>Tendered&nbsp;Pursuant&nbsp;to<BR>Guaranteed
Delivery<BR>Procedures</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.125% Senior Notes due 2021</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">126650BW9</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">CVS&nbsp;Health&nbsp;Corporation</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$1,033.32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$550,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$328,084,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$2,298,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.125% Senior Notes due 2021</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">008117AN3</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Aetna Inc.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$1,034.37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$500,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$297,403,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$2,346,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.450% Senior Notes due 2021</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">222862AJ3</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Coventry&nbsp;Health&nbsp;Care,&nbsp;Inc.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$1,053.11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$600,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$412,825,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$261,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Per $1,000 principal amount of Any and All Notes validly tendered at or prior to the Any and All Expiration
Date and accepted for purchase. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The settlement date for the Any and All Notes validly tendered pursuant to the Guaranteed Delivery
Procedures at or prior to the Any and All Expiration Date and accepted for purchase is expected to be August&nbsp;19, 2019, the second business day after the Any and All Settlement Date (the &#147;Any and All Guaranteed Delivery Settlement
Date&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CVS Health expects that it will accept for purchase all of the Any and All Notes validly tendered at or prior to the Any and All Expiration
Date, and all Any and All Notes delivered at or prior to the Guaranteed Delivery Deadline. The principal amount of Any and All Notes that will be purchased by CVS Health is subject to change based on deliveries of Any and All Notes pursuant to the
Guaranteed Delivery Procedures. A press release announcing the final results of the Any and All Tender Offers is expected to be issued after the Guaranteed Delivery Deadline. CVS Health will fund the purchase of the Any and All Notes with part of
the proceeds from the issuance of CVS Health&#146;s 2.625% Senior Notes due 2024, 3.000% Senior Notes due 2026 and 3.250% Senior Notes due 2029. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CVS
Health has retained Barclays Capital Inc. and Goldman Sachs&nbsp;&amp; Co. LLC to act as Dealer Managers for the Tender Offers (as defined in the Offer to Purchase). D.F. King&nbsp;&amp; Co., Inc. has been retained to act as the Tender and
Information Agent for the Tender Offers. The Offer to Purchase may be accessed at the following link: <U>http://www.dfking.com/cvs</U>. Requests for assistance relating to the procedures for tendering Notes (as defined in the Offer to Purchase) may
be directed to the Tender and Information Agent either by email at <U>cvs@dfking.com</U>, or by phone (212) <FONT STYLE="white-space:nowrap">269-5550</FONT> (for banks and brokers only) or (866) <FONT STYLE="white-space:nowrap">406-2283</FONT> (for
all others toll free). Requests for assistance relating to the terms and conditions of the Tender Offers may be directed to Barclays Capital Inc. at (800) <FONT STYLE="white-space:nowrap">438-3242</FONT> (toll free) or (212) <FONT
STYLE="white-space:nowrap">528-7581</FONT> (collect) or Goldman Sachs&nbsp;&amp; Co. LLC at (800) <FONT STYLE="white-space:nowrap">828-3182</FONT> (toll free) or (212) <FONT STYLE="white-space:nowrap">902-2995</FONT> (collect). Beneficial owners may
also contact their broker, dealer, commercial bank, trust company or other nominee for assistance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release does not constitute an offer to
sell or purchase, or a solicitation of an offer to sell or purchase, or the solicitation of tenders with respect to, the Notes. No offer, solicitation, purchase or sale will be made in any jurisdiction in which such an offer, solicitation, or sale
would be unlawful. The Tender Offers are being made solely pursuant to the Offer to Purchase made available to Holders of the Notes. None of CVS Health, the Dealer Managers, Tender and Information Agent or the trustees with respect to the Notes, or
any of their respective affiliates, is making any recommendation as to whether or not Holders should tender or refrain from tendering all or any portion of their Notes in response to the Tender Offers. Holders are urged to evaluate carefully all
information in the Offer to Purchase, consult their own investment and tax advisers and make their own decisions whether to tender Notes in the Tender Offers, and, if so, the principal amount of Notes to tender. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About CVS Health </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CVS Health is the nation&#146;s premier
health innovation company helping people on their path to better health. Whether in one of its pharmacies or through its health services and plans, CVS Health is pioneering a bold new approach to total health by making quality care more affordable,
accessible, simple and seamless. CVS Health is community-based and locally focused, engaging consumers with the care they need when and where they need it. The Company has approximately 9,900 retail locations, approximately 1,100 <FONT
STYLE="white-space:nowrap">walk-in</FONT> medical clinics, a leading </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
pharmacy benefits manager with more than 102&nbsp;million plan members, a dedicated senior pharmacy care business serving more than one million patients per year and expanding specialty pharmacy
services. CVS Health also serves an estimated 38&nbsp;million people through traditional, voluntary and consumer-directed health insurance products and related services, including rapidly expanding Medicare Advantage offerings and a leading
standalone Medicare Part D prescription drug plan. The Company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS
Health is shaping the future of health at https://www.cvshealth.com. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of CVS Health Corporation. By
their nature, all forward-looking statements involve risks and uncertainties. Actual results may differ materially from those contemplated by the forward-looking statements for a number of reasons as described in our Securities and Exchange
Commission filings, including those set forth in the Risk Factors section and under the section entitled &#147;Cautionary Statement Concerning Forward-Looking Statements&#148; in our most recently filed Annual Report on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> and in our most recently filed Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You are
cautioned not to place undue reliance on CVS Health&#146;s forward looking statements. These forward-looking statements are and will be based upon management&#146;s then-current views and assumptions regarding future events and operating
performance, and are applicable only as of the dates of such statements. CVS Health does not assume any duty to update or revise forward-looking statements, whether as a result of new information, future events or otherwise, as of any future date.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>cvs-20190815.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Addin 62.6.3 - Release 2019.1 -->
<!-- Creation date: 8/15/2019 11:24:54 PM Eastern Time -->
<!-- Copyright (c) 2019 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2019-01-31"
  xmlns:cvs="http://www.cvshealth.com/20190815"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.cvshealth.com/20190815"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2019-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" namespace="http://xbrl.sec.gov/sic/2011-01-31" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" namespace="http://xbrl.sec.gov/naics/2017-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20190815_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20190815_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.cvshealth.com//20190815/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>cvs-20190815_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Addin 62.6.3 - Release 2019.1 -->
<!-- Creation date: 8/15/2019 11:24:54 PM Eastern Time -->
<!-- Copyright (c) 2019 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>cvs-20190815_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Addin 62.6.3 - Release 2019.1 -->
<!-- Creation date: 8/15/2019 11:24:54 PM Eastern Time -->
<!-- Copyright (c) 2019 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cvshealth.com//20190815/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="cvs-20190815.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.cvshealth.com//20190815/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g791446g0814071156743.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g791446g0814071156743.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  3 &@# 2(  A$! Q$!_\0
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M?W:AADX)&[)!YZ#BL&UT/5M(T3PC8W>D7EXUOJK7MPD,8D6",I(H4Y.,Y<'
M]_2MSQ3IDLOC'0H[#1[@0+!=13W=O OEQF9-BDD$'@C)]!75'9'SE=1562B[
MJ[V->'X@Z%/=QQJUV+267R(M0:U<6LDF=H59<8.2, ]#ZT^_\=Z+I^H7%I)]
MLE6T.+RY@M7DAM3C.)' P#C\N^*X&P\.WTFAV'AS4+7Q;+<1"*WG@^T(EB%0
MCYUEVD;/E#!1\W08[UT%C)J?AJSUK0V\/7M_-<W=S/:3P1AH;E9F+#S')^0K
MNVG=V QFF8DC>+VNO$>DZEI]U>RZ+>:;=3FU-MRYB*[708W'.X]\'BL__A/K
MFYLO!VOR-=V=M?7#V]W9);EA*?)=EV KN;Y@H!'!IGA[3-6LT\$//I%Y']EL
M+C3[D>6,P2-L"EAG[GRGYJBTJWU2VTWP%:3Z#J@DTBY=;S]R"J?NGCW YY&7
M!R.P/I0!Z#H?B.QU]+@6RW$-Q;,%N+6ZA,4T1(R-RGL1R#T-%8VF+=K\3]<G
M?3KQ+2>RMHH[EH\1,T9D+<Y_VQCCUHH ["BBBCJ#"BBB@ HHHH **** "BBB
,@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>g791446g0815110227022.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g791446g0815110227022.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  = -D# 2(  A$! Q$!_\0
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M'>6M\VZ2,,<95B?U&.<9!S73_$;Q_<Z/H^DVOAI5N-8UYE6Q)&0JMCY\'O\
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MM+65VDEO+@>:YZX)RQ_+->U_$;P5'XFFL;H7GV6:)6C)\K?O7@CN.G/YU0\
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1/O\ HH]Q_P""R/\ ^*H _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>g791446g70l27.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g791446g70l27.jpg
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M P,# P,# P,# P,# P,# P,# P,#_\  $0@ #@$L P$1  (1 0,1 ?_$ 'P
M 0$! 0$! 0            H)" 8'! 4! 0$!                   " 1
M  8" 0,"! 0$! <      0(#! 4&!P@) !$2$Q4A%!8*,2(7&$%1,B-A<8$9
MH6(SAY<H2!$!  $%                  $1(3%A(O_:  P# 0 "$0,1 #\
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M(V;]:\6;8Y!Q]I7FS*H/U[=D# T4@W.R5&<DFK1[9(:(=G*FU>*$-W%4Y $
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M;XVG+9/S%FF5\N;#HJRT[)/):250:9>L[9H@J]?*K.%$FR"8$(43=BD* !\
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MB)DD5TQ\1"5WV^J$'!<E5JM]!/@"Y06:<2YF?0.)Z-8LY-1TPQXTS$HO,P>
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? $L_;]_\P?M6_P"U7[?>_N'_ (Y[^[?Z_,_\_0?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>d791446d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cvs-20190815.xsd" xlink:type="simple"/>
    <context id="d_2019-08-15_to_2019-08-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2019-08-15</startDate>
            <endDate>2019-08-15</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="d_2019-08-15_to_2019-08-15"
      id="Hidden_dei_EntityRegistrantName">CVS HEALTH Corp</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="d_2019-08-15_to_2019-08-15">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="d_2019-08-15_to_2019-08-15"
      id="Hidden_dei_EntityCentralIndexKey">0000064803</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="d_2019-08-15_to_2019-08-15">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="d_2019-08-15_to_2019-08-15">2019-08-15</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="d_2019-08-15_to_2019-08-15">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="d_2019-08-15_to_2019-08-15">001-01011</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="d_2019-08-15_to_2019-08-15">05-0494040</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="d_2019-08-15_to_2019-08-15">One CVS Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="d_2019-08-15_to_2019-08-15">Woonsocket</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="d_2019-08-15_to_2019-08-15">RI</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="d_2019-08-15_to_2019-08-15">02895</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="d_2019-08-15_to_2019-08-15">(401)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="d_2019-08-15_to_2019-08-15">765-1500</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="d_2019-08-15_to_2019-08-15">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="d_2019-08-15_to_2019-08-15">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="d_2019-08-15_to_2019-08-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="d_2019-08-15_to_2019-08-15">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="d_2019-08-15_to_2019-08-15">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="d_2019-08-15_to_2019-08-15">CVS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="d_2019-08-15_to_2019-08-15">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="d_2019-08-15_to_2019-08-15">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6627412784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Aug. 15, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CVS HEALTH Corp<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000064803<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 15,  2019<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-01011<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">05-0494040<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One CVS Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Woonsocket<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">RI<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02895<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(401)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">765-1500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CVS<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>15
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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MZP^_J[#OK-N[?VQ\$=0U_+H+_0502P,$%     @ 18(/3YE<G",0!@  G"<
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M.AQG0GS/]O:1I24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG
MLR+7E$8D19_(+;KD$3BU20TR$S\(G8:8:E < J0),9:AAOBTQJP1X!-]M[X(
MR-^-B/>K;YH]5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J
M-2S%UGB5P/&MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZ<TT#PE"\D^DJ1
MCVFS(Z=T)LWH,QK!1J\;=8=HTCQZ_@7YG#4*')$;'0)G&[-&(81IN_ >KR2.
MFJW"$2M"/F(9-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.
M$9)>-T(^8LZ+D!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]07
M2N0/)J<_Z3(T!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!
M_]':-\*K^(+ .7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7
M<LW(QU2ODRG8.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD
M6R4)RU3393>*$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W
M<DOJMI2^M28X2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-M
MNIW<.CB>F)&Y"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(
M\J(A[J&&F,_#0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R
M4E5@,5O& RN0HGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>
M9;'!51W/55ORL+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4X
MOT4SMA*7&+SCYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5
MYYN<KGHB=OJ7=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(C
ME1P&%A<RY%#NDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>
MTB42%(JP# 4A%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+
MA=OB5,V[&KXF8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y
M,M\Y<-LZW@->YA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,
M?-2K6J5D*Q$_2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:
M,]6+K#F-"F]!U4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_
M 5!+ P04    " !%@@]/"ZJ<K9H"  "3"P  &    'AL+W=O<FMS:&5E=',O
M<VAE970Q+GAM;'56[8Z;,!!\%<0#'-B03Q&DYJJJE5HINJKM;R=Q CJ#J>V$
MZ]O7!H(B[_I/P&9FQ_9XE"UZJ=YUQ;F)/AK1ZEU<&=-MDT2?*MXP_2([WMHO
M%ZD:9NQ071/=*<[. ZD1"4W39=*PNHW+8I@[J+*0-R/JEA]4I&]-P]2_/1>R
MW\4D?DR\U=?*N(FD+#IVY3^Y^=4=E!TE<Y5SW?!6U[*-%+_LXD]DNZ>Y(PR(
MWS7O]=-[Y+9RE/+=#;Z==W'J5L0%/QE7@MG'G;]R(5PENXZ_4]%XUG3$Y_='
M]2_#YNUFCDSS5RG^U&=3[>)U')WYA=V$>9/]5SYM:!%'T^Z_\SL7%NY68C5.
M4NCA-SK=M)'-5,4NI6$?X[-NAV<_?LD?-)Q )P+U",DH-*S\,S.L+)3L(S4>
M?L><QV1+[=F<W.1P%,,WNWAM9^]E6B1W5V9"[$<$?4*0&9'8VK, 107H0,^>
MZ!2G9R@]&^CY$SWSU@<1.2Z0HP(YH"\\ 8A8X@(+5& !Z"M/ "+6N, 2%5@"
M^L83@ B2X@HK5&$%^<230" !G]>HQ!KR?:,12,#I#2JQ@7S?:@02\)JD>)Q2
M6,&W&\,$#">!T!)8P?<<P=" Z01/+J&P@F\[A@GX3O" $YA?ZCN/80+6$SSE
M!(:8^N9CF)#[>-0)3#(%[B.8D/MXW@F,,P7N0TP6<A_//(&)SH#[$!,Z,#SU
M!&8ZH[X(Q(1$\-P3F.H,W#"("8A0//@4ACK+/1$$$Q+!<T]AIC/_%F.8D$K@
M'QMF.O-O,88)W&**YYXB_^S^+48P>> 64SSW%&8Z]V\Q@O$/+'EJIUR[^H.I
M:]WJZ"B-[<R&_NDBI>&V7/IB U[9#GD>"'XQ[G5EW]78)HX#([NI!4[F/KS\
M#U!+ P04    " !%@@]/[O+NY48"  #L!0  %    'AL+W-H87)E9%-T<FEN
M9W,N>&ULA51-;]I $#VGOV*$>F@EP&L*%"J"A( T*)2@@!JU50^+/=BKVKO.
M[IK O^\8$E1Y<>.3[7GS9N;-Q\ 8"[D43SF.52[M=:W=JL$^3:2YKL769E\\
MSP0QIMPT58:2+%NE4V[I4T>>R33RT,2(-DV\%F-=+^5"UH8#(X8#.YRH($]1
M6N RA*FTPAY@)D\,0LF!9X<#KX">X*,\:H+?J4.+^?VR<:QVJ.'7:&.LYH']
M7;:_T#]@) H$!5WP%!V6[RNXG8[FZUL8*YTY&5"VX3'CFX1'9>N6)\9A?(D[
M)B?-$RHOQ#W<X:&,8\73;??8I[+EK-+ZD#GTO<9=)7Z)6JA"V! FW#JNKW*^
MN[JZ).BY'P$)H?2Q(["R1 3'6=!4E H=ULFT@NA&) B+/-V@=FOW&\QGOE_A
MNN9[F(54DMB*X)1(!5&GP=K]-FNS"J91&&HTIO[Z G,A$>ZE4P;]@F(8)EKL
MJGIZ)AL77TK#6CT[0_NHE#0J^(/V+9:3MD2SU&HG9."$?9B]1;%4QM*0_139
MQ=ZP5J_?<4;^R$"+>M'E0YOY'\L_YRJ@*,M8R:J.?NYV&GZ'.6UXU,):E!0J
M3>FNG)IIRJB52D0@K) 1?"--M.!)&;+4>"1!TNFT'+29= #NMULW&P<\,R8G
M\/]\5ACDNI#&;VU@+6SBW@IB/*X$=;<.&=>PXTF.\)XUF0\9$9N8:\=MK7E8
M5+8ZI!OEU$4S5YG)=!_$7$9X\7(M?JRJ-F^:HHZ*D%^U>K9Q(47&Y3\7R*,S
M/_P+4$L#!!0    ( $6"#T^ZH3F*UP$  #(&   -    >&PO<W1Y;&5S+GAM
M;-556XO5,!#^*R$_P)QVV06E+>C"@J"RL.?!U[2=MH'<3*?'=G^]2=/;T0?Q
MX(.^-#/?3+[Y<IDTZW&2\-(!(!F5U'U..T3[CK&^ZD#Q_HVQH'VD,4YQ]*YK
M66\=\+H/DY1DZ>GTP!07FA:9'M23PIY49M"8TQ-E1=88O2-W- (^E2L@%RYS
M^LBE*)V8<[D2<HIP&H#*2.,(>BF0TR0@_6L,)]$+*A<>);1Q 62Q0OR62_I/
M@=7KO2NDW 2F- )%9CDB./WDG3EY!G\)D<4^3]8K;!V?DO2>[A/FP1<IC:O!
M;642ND)%)J$)<IQHNS"BL2P$$8WR1BUX:S2?-:PS%L/35B#E2SC"K\T5]]B0
MF/.Q#L= @HK5]*M>S'A<T0G\1[;(?:"]OXF66'$Q^&'PJ]&S_VTP",\.&C'.
M_MAL]3T[MU9.[Z5HM8*XEM\63&XL6&1\K4,ZX\2KYPLWI?( .$HNX%!41^2[
MX_8,(ZZW:6QNU9S^AYK_]CZWH,%Q>13MK_Z_O,M_HI@MW7-HT:L&W5!2#D*B
MT(O&3M0U1'GAA<SIE_#PRJL^V?O4TR,O_0-^Q>_GUM#P0>)S6/$<S.EN?PHO
M3?*P99TWBISN]F>HQ:#>S@7WOT3Q U!+ P04    " !%@@]/%FTC?T,!   \
M @  #P   'AL+W=O<FMB;V]K+GAM;(U1RV[",!#\%<L?T 34(A41+J4/I*I%
MI>+N)!NRPH_(WD#+UW?M*(7>>K)W=CP[.UZ<G#^4SAW$E]$V%+(EZN99%JH6
MC HWK@/+G<9YHXA+O\]"YT'5H04@H[-IGL\RH]#*Y6+4VOCLNG $%:&S#$9@
MAW *EWXLA6+"$3Y56<A<"M63>T)-X%>*X-F[OD.[+^1$B@9]H&V<G9@&+1H\
M0YVJT+K3B_-X=I:4WE;>:9U>Q49ZQ!/"+[(#3UC](9(J/Q1[+>0L9\$C!BQ1
M(WT7,MTU2-XBNUHCY3">0XAS_Y\87=-@!2M7]08L#3EZT'&Z#2UV00JK#!1R
MI AE:_%HB=V(M1VDF!MWX='K>MB+.+&+6>'GR V_KB?)^.BVA@8MU&\\(##.
M(50;+^*1=*:W=Y-[#KO7^H&Q=_OJ5-*/&N/'+7\ 4$L#!!0    ( $6"#T__
MP"8(O0   (4"   :    >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'.MDD$*
M@S 0 +\B>4!7;>FAJ*=>O+;]0-#5B)J$[);J[YMZ44&A!R\)8</,0)(\L)/<
M&$VJL10,?:<I%8K9W@"H4-A+.AF+VD\JXWK)_NAJL+)H98T0A^$5W)(ALF3)
M#/(R%2XO(Q&\I*N14P%#!Q_C6E*(3#!MT<D+_)71XC]Z4U5-@7=3O'O4O%$Q
M"P1L!\5S$"GIL'RR:W1-1X>LX'LQYT4,CQT>7S%1]_276<]>@C"MA[_)1/TU
MP.K795]02P,$%     @ 18(/3PN/V ,A 0  5P0  !,   !;0V]N=&5N=%]4
M>7!E<UTN>&ULM51-3\,P#/TK4Z]HS>#  6V[ %>8!'\@)&X;-5^RO=']>]QN
M0V(J8FC;)8GS[/=>$BOS]VT&FG3!1UH4#7-^4(I, T%3F3)$0:J$0;.$6*NL
M3:MK4'>SV;TR*3)$GG+/42SG3U#IM>?)XVZ_IUX4.F?OC&:7HMI$>T0ZW1.6
M"'[(H<9ENI&$8O+<"0O)WJ(0E IU@L)Q81]+W>L&$)V%?UE+5>4,V&3604I*
MR@C:4@/ P9?4: 3[QNABO?>[TL@O.@BQZKSZD5!>SP=O/8P;&)!+*K.T!8Q)
M#<!NO#U+\- -)B%,,PJ*[$:.)Y96@I+J$R]Y1.A;QX(]25RHK_>PGPG;83UV
MX=\@J6$Z[];_:'29RZ!=_,W(1TKM05\-_\GR"U!+ 0(4 Q0    ( $6"#T\?
M(\\#P    !,"   +              "  0    !?<F5L<R\N<F5L<U!+ 0(4
M Q0    ( $6"#T\GZ(<.@@   +$    0              "  >D   !D;V-0
M<F]P<R]A<' N>&UL4$L! A0#%     @ 18(/3]&M;;_O    *P(  !$
M         ( !F0$  &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ 18(/
M3YE<G",0!@  G"<  !,              ( !MP(  'AL+W1H96UE+W1H96UE
M,2YX;6Q02P$"% ,4    " !%@@]/"ZJ<K9H"  "3"P  &
M@ 'X"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ 18(/
M3^[R[N5& @  [ 4  !0              ( !R L  'AL+W-H87)E9%-T<FEN
M9W,N>&UL4$L! A0#%     @ 18(/3[JA.8K7 0  ,@8   T
M ( !0 X  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " !%@@]/%FTC?T,!   \
M @  #P              @ %"$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%
M  @ 18(/3__ )@B]    A0(  !H              ( !LA$  'AL+U]R96QS
M+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ 18(/3PN/V ,A 0  5P0
M !,              ( !IQ(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&
/  H "@"  @  ^1,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.19.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>97</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d791446d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com//20190815/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d791446d8k.htm">d791446d8k.htm</File>
    <File>cvs-20190815.xsd</File>
    <File>cvs-20190815_lab.xml</File>
    <File>cvs-20190815_pre.xml</File>
    <File>d791446dex41.htm</File>
    <File>d791446dex42.htm</File>
    <File>d791446dex43.htm</File>
    <File>d791446dex51.htm</File>
    <File>d791446dex991.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>g791446g0814071156743.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>21
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d791446d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d791446d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cvs-20190815_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cvs-20190815_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "cvs-20190815.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd",
      "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 97,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "cvs",
   "nsuri": "http://www.cvshealth.com/20190815",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d791446d8k.htm",
      "contextRef": "d_2019-08-15_to_2019-08-15",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.cvshealth.com//20190815/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d791446d8k.htm",
      "contextRef": "d_2019-08-15_to_2019-08-15",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20190815/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20190815/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20190815/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20190815/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20190815/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20190815/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20190815/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20190815/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20190815/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20190815/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20190815/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20190815/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20190815/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20190815/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20190815/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20190815/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20190815/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20190815/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20190815/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20190815/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20190815/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20190815/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>22
<FILENAME>0001193125-19-222479-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-19-222479-xbrl.zip
M4$L#!!0    ( $6"#T]D$E)[8@,  "4,   0    8W9S+3(P,3DP.#$U+GAS
M9+U636_;.!"]%^A_F-5I"ZQ$RZG36HA3!)L&")!F"S<M>BMHBK:)I4B5I)+X
MW^^0DFS9L5T[*3:7T)QY,V\^J;,/CX6$>VZLT&H4I4DO JZ8SH6:C:+*QM0R
M(:(/YZ]?G?T1QW!Y=7T+,<R=*VU&R,/#0Y)/A;):5@XMV(3I@D <M_I_WWV%
M;[7U#"YR- NG_>0T.4$C8RXYM1SZO728I%V0X=1;@YPZGL%[D@Z(5X(TS?IO
ML\%;^/P)/E+KN%%P)PK>Q>IR8<1L[N!/]B:8ADNM%)>2+^!***J8H!*^M(3_
M@FO%$KB0$L8>9I&6Y>:>YTEC]='FF65S7M#7KP P7<IF"DU6Q2CR>6C2\#@Q
M,M%F1G)GB%N4G*!2C%K<"!9UH+_&/<%@';S$+H%3:B<!U$I"?N)>&I^D'1R[
MMVN^\/><4^GFH4P>TGN?#CJ G(LE(!"SG"4S?4]0L-V%UQ+; ^KW>B<$>\-A
MSGD'(H7Z=P_"BR?8%UTG3R /)P&0#H=#$J0;E'*W'D=C?4!J84?;"K8]9!3X
MD--.R-0Y(R:5XU?:%)=\2BN)?BKULZ)23 7/@Q:V=<&56]-9UW#4S+B[I06W
M)67\N!IA/VY+!4:7DN^?;KZ$5HW./0 @=*\H2FT<U$U\HUD8KCT5\+_BMG"Q
MOXK3/N8@06,1J*VT=U0=R(N)M/WP+"++9CJ8B-W5^OX0KV9@%X=]8_/L;&SN
M!I^+H<]%>GI0+I[LEM_ 1*O;EY+I+,AC"&T=4W^(5_-Z4'DV1OSY/:*H8&$'
MOZN/GLB[(XBL\"_ME,Z2\W49['6_N14;K\$G54J[X*C+A):E4%/=7.&E'["L
MG;(QGT+8QADUS&C)]^]L4AI=<N,$OE^K0:T-S V?CB)<AG&[ G](.DEP!;8:
M3^RO3[X7$X1P>;-BUV*=<!Y\X\7@Y?@=0.72M._.460Q[;*S.?[?:$O#CXT6
M(18?GE"TW4%_[F@=';OW<X<:X ]?Q]=[GJ[EVT4<?=1*%XN:Y:5FE7\?V_\7
M*O^HD-OB&AO+%(%7! (?N3&J_SA(?<FRY9ES_"H5H7O3GO_#[\W60O=(50ZU
M.>C8.R.;1C;M5Y;G_ZCS<&94LDHNL]Z &XU]P,UZ'8Y<,=N-:V[;BK533#;'
MN+GICGM]5:\;_/D?4$L#!!0    ( $6"#T]Y(NI?9 8  $=$   4    8W9S
M+3(P,3DP.#$U7VQA8BYX;6S-G&UOVS80Q]\7Z'>X>6\VH+*CI"T6(TD1.,D0
M+&F"QMV&#4,A2XQ-3.89I)S8WWZD'AHYIF0I.DUYT5:5CO^[O_P[AGIPCCZM
MYB$\,*DXBN.>V]_K 1,^!EQ,CWM+Y7C*Y[P'*O)$X(4HV'%OS53OT\G;-T<_
M. Z<75Q^!@=F4;10P\'@\?&Q']QSH3!<1EI2]7V<#\!QLOC1^"O\GJ0;PFF@
M\\#'_?['_H$6^<)"YBD&^WON8=_-#Y+,,VH0>!$;PB\#]\/ !('K#O??#S^\
MA]MK./=4Q*2 ,9^S_%A<K"6?SB+XR?\YEH8S%(*%(5O#!1>>\+D7PEU6\#NX
M%'X?3L,0OIAA2I>EF'Q@03]5#;GX=VC^FIABX>T; 'T2A8KW'??,J4C/Q&HB
MPS[*J2YV[V"0#>D]C5AM#7D\B >XAX>'@_AH/EIQ6ZP6=P=_7E_=^3,V]QQ]
M\O6'Y:=I%!^J>/\5^O$YK% @%$:8_SE9F&-V.>Z^<^#V5RKHG9B$Z=GQ)BR\
MTEL0>QA*#%E)8G,XSMY+XZ/U0L>S5<1$P%+E[]KHIU$SR>X358->+*F8WY_B
MPR!@/";$;#AFP]ESTSI_U+N^C5 S?SI1D?3\:#-K:$X4RFQG;.6X9QDTV"S+
MQ)U*?T/+DWZFHS=WG(4T8N"C_O06D1,K9L/O)<ZM5:3IT'+P6S@)K64:GO26
M:7$FG*]WN[PF0GECDBE<2@U9G0\X]G,2*\/?F?8_1X.GW*^E5#V1*'95MUX*
M,,]%Q*/U%S;E)IV(/GMS5I5/^]B.,"TU@L4Q3: MUB-B-TD 3QG I&A,<'MU
MYT&N6SP%SJ=S/8/K/]%%Z$VK<OQL4$< VTM'R\$FR%J$B%C]K@Q&NC&C+12:
MA[-JM71S[$@GDUYXJ5<8J]_8NMXDNS6XTUFVR J6!#6?9ZV"M!-MF@+B'*"3
M$$VUK91NF6MKU$\!]AGZ2]-#8^VA*L^;8SK"V%HX;A]K NVV#A&KF3 8Y<:
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M0^8,AK)IE.HP;\_G $&QYTOIC_ S(Y@2X;N.33ZHC3;"I4W#^#E<N2C]H(E
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MN<R<DB*Y41:RC;<^Q>(5M+?-X"XA_XY2NHW\*=V.9*.0'! =E,B6^<_G9A&
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M@M.;Q>M13:Z2"%7(K\ZQX"%?A6"W6+WJWAU%82%>(]+;<.V7-@[6/:O5:A&
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MO'R,V)&[.PI/5FV+*3=6$_T2UTS1&/BI%#W;G ^?;2( *%9VI60$*GHXF2B
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M+&SAR8)[R5SY$*F1*1%U9L#FKI53&)M:HTGO*9"H/V](9GWM.29S34P&;)V
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M?T9SZO7UYM3.J[W3@R_PY6'_^&CW_P!02P,$%     @ 18(/3T^"CEV')P
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M\416G#H@8X2<VD%H!WE!$079-KS,SX=B[SA<-H@-55>'X.NUA1@\[DV7(?A
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M_=S=:PTZ CZ>]#K]SM&@TQ:[WT3K2+1.!_O'O>[_PA>]COFQ->C^V1''GV&
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MOI*Q&DJP%V44H2)+9GW%5.*2F<H[EWX<(HB22'L)Q\'D4/M8#&20QPY,SH6
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M#JQ>&U/7/KO"Y]C0O3+$LR?($'MJED;>1,:JZ.L[Q7")%'N<QH=5C#!H%/K
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M3MK]=]W.]?O.9>/TZOVL+KO"SW_;S>]_<\K^2' -O]GUO>3CY(CUC= 1,AJ
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MN$33B.V4"\D7RA$K;>':GSX(<L4S1.X T_V"@QU=%;&A12=C+$(>U=DM6*2
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M7C%MOB[=$,AI10+H5*ND(:/K]&(T-%X%;[ZNK5VE6#A8OTS5(')M&L%D$$1
MZ^&<8)Y-7-N>E]R9 _>": @J5')_#ILM0H>SOF.6XTVD.VDH<:E&^:!1>7BI
MKGL'$N'/$Q[AOC!H=H/Q=4"0"."BQ<)K$T8(,Y1WPIXK)!-:5M?14@'IC@4,
M]]E,PKKX8C[YTY.NVYMR-A[9N<AUB.4;)Y4*\\K3LE$LX,,OKO^5=64(L@$O
M& S51UH6#[0LKN'^E((YYZ%(MC  ,0-)#=46G9??E=D?TAEKZ\"G'HBU6XZW
M">?64H$3]QT0AZG696/87!(/'+16\ PMR](QI0>FG4]!DA="GGH/T"9.LF6
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MC?IT]$%274KBBT1]!I%/H0M(H!5AX@S'4QQ#]%#P&8OF( Q$CU)C"\P^$OV
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MLD,\VB3_[/?:22;Z U!+ 0(4 Q0    ( $6"#T]D$E)[8@,  "4,   0
M          "  0    !C=G,M,C Q.3 X,34N>'-D4$L! A0#%     @ 18(/
M3WDBZE]D!@  1T0  !0              ( !D ,  &-V<RTR,#$Y,#@Q-5]L
M86(N>&UL4$L! A0#%     @ 18(/3[2::_.Y!   !BL  !0
M ( !)@H  &-V<RTR,#$Y,#@Q-5]P<F4N>&UL4$L! A0#%     @ 18(/3_D,
M_SL^$@  >)    X              ( !$0\  &0W.3$T-#9D.&LN:'1M4$L!
M A0#%     @ 18(/3\KV&W..)P  (]D  !               ( !>R$  &0W
M.3$T-#9D97@T,2YH=&U02P$"% ,4    " !%@@]/3X*.78<G  "#V0  $
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I-F<P.#$T,#<Q,34V-S0S+FIP9U!+!08     "@ * 'P"  !;P      !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
